Académique Documents
Professionnel Documents
Culture Documents
xxvi
Blueprints Urology
VP Ventriculoperitoneal
Diagnostic
VSD Ventricular septal defect
VUR Vesicoureteral reflux
VZIG Varicella-zoster immune globulin
Microbiology
VZV Varicella-zoster virus
WB Western blot
WBC White blood cell count
arin L. McGowan, PhD, F(AAM) and Deborah Blecker Shelly, MS
WEE Western equine encephalitis virus
--------------------------------------- 2
10
Microscopy/Direct Examination
Giemsa stain: Best stain for all blood parasites and microfilaria,
Acanthamoeba, Naegleria, Microsporidia, Toxoplasma, P. carinii
--------------------------------------- 3
100
101
Co
abscess formation
Local erythema, warmth, and pain
rther classification is by depth of involvement of the hair follicle
Constitutional symptoms common including fever, chills,
- Folliculitis: Small abscess with limited surrounding tissue reaction
malaise
- Furuncle: Deeper nodule with more intense tissue reaction
If secondary to wound infection: Preceding puncture wound,
still involving a single follicle
insect bite, laceration
- Carbuncle: Multiseptate, loculated abscess; aggregate of
If hematogenous seeding: URI prodrome followed by fever
infected hair follicles
with simultaneous appearance of local erythema
Fu
Epidemiology/Risk Factors/Etiology
Physical Examination
sk factors include wounds from injuries, bites, or surgery; hot
Tender, indurated, edematous area of subcutaneous tissue with
tub use
overlying warmth and erythema
S. aureus predominates
Indistinct lateral margins secondary to process lying deep
t tub folliculitis usually due to P. aeruginosa
within subcutaneous tissue
Regional lymphadenopathy and lymphangitic streaking
thogenesis
Additional Studies
avy skin colonization with S. aureus favors development of
folliculitis
Culture of aspirate from site of inflammation
rtal of entry created by preceding site of skin trauma allows
Blood culture positive in less than 10%
pathogen to invade
Differential Diagnosis
story/Physical Examination
Deep venous thrombosis; ruptured baker's cyst; erythema
eceding history of trauma, wound, irritation, hot tub use
nodosum; insect bites; septic arthritis; osteomyelitis
Pustules commonly found on extremities, buttocks, or scalp
Ri
Ho
Pa
He
Po
Hi
Pr
--------------------------------------- 4
102
more likely
isms, and P. aeruginosd) and anaerobic (Peptostreptococcus,
Bacteroides fragilis) infections
Additional Studies
ype II: Group A Streptococcus (GAS) (most common)
Gram stain and culture of purulent material
Pathogenesis
Differential Diagnosis
ollowing trauma, surgery, or other conditions, skin becomes
cellulitis
Pyrogenic exotoxins from GAS strains lead to cytokine production and tissue damage
Management
nfection spreads along fascial planes, eventually producing
tures
Necrotizing Fasciitis
Differential Diagnosis
Extensive cellulitis with severe involvement of subcutaneous
Severe cellulitis; pyomyositis
tissue including fascia, muscle, or both resulting in tissue
necrosis
Management
Urgent surgical drainage and debridement, antibiotic therapy,
1 Epidemiology/Risk Factors
hemodynamic supportive care
Type I: In patients with diabetes and peripheral vascular disInitial antibiotic therapy should provide coverage for aerobic and
ease (mainly adults)
anaerobic organisms: Combination of clindamycin or penicillinaseType II: All age groups including neonates
resistant penicillin plus an aminoglycoside (e.g., gentamicin), or a
--------------------------------------- 5
Cha
pter I
104 Blueprints Pediatric Infectious Diseases
third-generation cephalosporin, or a p-lactam/|3-lactamase
inhibitor combination. If etiology is GAS, the combination of a
Bone and Joint
p-lactam (penicillin or cephalosporin) and clindamycin is
probably superior to the (3-lactam alone (Eagle effect)
Infections
In patients with streptococcal toxic shock, consider use of
IVIG (neutralization of circulating streptococcal toxin; see
Chapter 15 for toxic shock syndrome)
Jane M.Gould, MD,FAAP
Complications
Septic Arthritis
Streptococcal toxic shock syndrome; loss of limb; death
Microbial invasion of the synovial space
Epidemiology
One third to one half of cases occur in children younger than 2
years
90% are monoarticular; large joints (knee > hip > ankle >
elbow) most common overall
Lyme affects knee in 90%; Neisseria gonorrhoeas affects distal
joints (hands, wrists, knees)
Risk Factors
Most children previously healthy
Occasionally preexisting joint disease (e.g., rheumatoid arthritis) or impaired host defense (e.g., malignancies, primary
immunodeficiency, steroids)
Etiology/Pathogenesis (Table 14-1)
Three main mechanisms: 1) Hematogenous spread via synovial
membrane (most common); 2) direct inoculation or puncture
of joint space by contaminated object; 3) contiguous extension
from an adjacent osteomyelitis in neonates and young infants
History
Acute onset of fever, limp, refusal to walk, refusal to use limb
Lyme arthritis may be preceded by erythema migrans rash; few
systemic symptoms
N. gonorrhoeae preceded by fever, chills, tenosynovitis, and polyarthralgias
Physical Examination
Abduction and external rotation typical with hip involvement.
Bacterial arthritis: Joint swelling, warmth, erythema, decreased
mobility, exquisitely tender
105
--------------------------------------- 6
106
107
Enteric GNR
Empiric intravenous antibiotics (alter therapy based on organInfant
S.aureus
S.pneummiae
ism isolated)
S.pyogenes
H.inttuenzae"
- Neonate: Oxacillin/vancomycin + aminoglycoside/cefotaxime
K.kingae
Salmonella sppf
- Infant or child: Oxacillin/cefazolin/ceftriaxone (vancomycin
Older child/adolescent S.aureui
H. influenza?
if high methicillin-resistant S. aureus prevalence)
N.gonorthoeae
S.pneumoniae
- Adolescent: Consider ceftriaxone (for N. gonorrhoeae)
S.pyogenes
Salmonella spp.
Lyme: Initial amoxicillin or doxycycline (ceftriaxone for treatment failure)
" H. influenzas type b in unimmunized populations.
Duration of therapy varies by organism: Typical bacterial
6 Salmonella in patients with sickle cell disease.
arthritis, 2 to 3 weeks; Lyme arthritis, 4 weeks; N. gonorrhoeae,
7 to 10 days. If associated osteomyelitis, duration as for
Lyme arthritis: Swelling and erythema out of proportion to
osteomyelitis
In older children without hip involvement or associated
tenderness
osteomyelitis, consider switching to oral therapy after clinical
N. gonorrhoeae: Hemorrhagic papules/pustules on extensor
and laboratory improvement documented (consult infectious
surfaces and over affected joints
Multiple joints may be involved in gonococcal infection and in
diseases specialist)
neonates
Needle aspiration for all joints. Open surgical drainage and irrigation if 1) hip or shoulder involved; 2) persistent/recurrent
symptoms; 3) penetrating joint injury; 4) neonatal patient
Additional Studies
Blood cultures positive in 40% of cases.
Joint aspiration of synovial fluid for culture positive in 50%
Complications
Osteonecrosis; growth arrest; cartilage damage, stiff or unstable
--------------------------------------- 7
108
109
Etiology
Recommended Agents
Duration
Symptoms, including fever, usually present for less than 2 weeks
Most frequent manifestations include fever, pain at site of
MSSA
Oxacfllin/cefazolin/dinclamycin
3-4 wk
infection, and refusal to use limb
MRSA
Vancomycin/linezolid
3-4 wk
Less common manifestations include anorexia, malaise, and
Streptococci Penidllin/ampiciliin
3-4 wk
vomiting
Raeruginosa Ticardllin/piperaciHin + aminogtycoside7-10 d with
debridement
i Physical Examination
Salmonella Arnpicillin(ifsensitive)/cefotaxime/ceftriaxone3-4 w/k
TMP-SMZ
Limitation of use of involved extremity or area
K, kingae
Penicillin (if sensitive)/ cefotaxime/ceftriaxone3-4 w/k
Localized swelling, warmth, erythema, and pain
TMP-SMZ
Special considerations
- Pelvic osteomyelitis: Hip and/or abdominal pain, difficulty
" Specific therapy should be altered based on susceptibility testing.
walking, rectal mass
--------------------------------------- 8
110
--------------------------------------- 9
112
113
--------------------------------------- 10
114
catheters
Infections range from localized infections (exit site, tunnel
History/Physical Examination
tract, and suppurative phlebitis) to systemic infections (bacFever without clear source of infection in presence of a CVC
teremia and fungemia)
Local infection (confined to exit site): Erythema, tenderness, or
purulent discharge
Epidemiology
Signs of systemic illness
Incidence of exit site infection is 0.2 to 2.8 per 1000 catheterdays
Additional Studies
Incidence of CVC sepsis is 1.7 to 2.4 per 1000 catheter-days
Incidence of implantable device sepsis is 0.3 to 1.8 per 1000
Local infection: Gram stain and culture of any purulent discatheter-days
charge from exit site
Systemic infection: Blood cultures from the catheter and a
Risk Factors
peripheral vein
- CVC-related infection if 1) quantitative blood culture with
Depend on the device/product inserted, insertion site, and
5:1 ratio or higher (CVC vs. peripheral) of colony count or
duration of CVC insertion
100 cfu/mL or higher from CVC culture; 2) differential
Higher rates in 1) premature infants compared to older chiltime to positivity (e.g., positive result of culture from CVC
dren; 2] intensive care units compared to general wards; 3)
those receiving certain infusates (e.g., parenteral nutrition,
appears 2 hours or more before positive result from periphcontaminated fluids)
eral culture; or 3) same organism from CVC and peripheral
blood sample and 15 cfu or more of that organism from
CVC tip
Etiology/Pathogenesis (Box 15-2)
Interpretation of contaminant vs. pathogen affected by age and
comorbidities.
Differential Diagnosis
Routes of infection: 1} Inoculation at time of CVC placement;
Sepsis, cellulitis, phlebitis, drug-related fever, viral infection
2) inoculation during CVC manipulation (breach in aseptic
Management (Table 15-1)
BOX 15-2 Causes of CVC-Related Infections"
Decision to remove CVC depends on 1) severity of the patient's
condition; 2) evidence of catheter-related infection; 3) type of
Common Organisms
Coagulase-negative staphylococci
organism infecting the device
Staphyiowcais aureus
- Must remove catheter if 1) candidemia; 2) S. aureus infecAerobic gram-negative bacilli
tion; 3) persistently positive blood cultures despite antimiCandida albicam
crobial therapy; 4) tunnel infection
Start antimicrobial therapy after obtaining blood cultures
Less Common Organisms
- Empiric: Combination therapy with oxacillin or vancomycin
Corynebacterium species
plus an aminoglycoside or third-generation cephalosporin.
Bukholderia cepacia
Alternate options include monotherapy with imipenem,
Stemtrophomonas maltophilia
meropenem, or cefepime (methicillin-resistant Stapkylococcus
Mytobacterium species
aureus is not covered with this regimen)
In the neonate, the most common organisms causing infection are coagulase-negat
ive staphylo- CVC-related candidemia: CVC removal plus antifungal therapy
cocd > Candida spp. > enterococci > gram-negative bacilli.
- Empiric antifungal therapy: Amphotericin B or liposomal
derivative (see Chapter 4)
--------------------------------------- 11
116
117
Pathogenesis
TABLE 15-1 Approach to Management of Uncomplicated
S. aureus strains can produce exotoxin (TSS toxin-1) and
Central Venous Catheter-Related Infection
enterotoxins
Duration
S. pyogenes strains can produce at least one of five pyrogenic
Organism (days)' Comments
exotoxins
CoNS 10-14 May retain CVC unless clinical deterioration or persisting
or relapsing bacteremta. If catheter removed, may shorter
History/Physical Examination
duration of treatment to 5-7 days
Major criteria (all required): 1) Fever (greater than 38.9C); 2)
S.aureus 14 RemoveCVC;lfechocardiogramrevealsvegetations,treat
for 4-6 weeks
diffuse macular erythrodermatous rash that desquamates 1 to
2 weeks after disease onset. Can localize to the trunk, extremiEntemcoccus 10-14 Usually treated with combination of vancomycin,ampicillin,
ties, or perineum; 3) hypotension
or penicillin plus an aminoglycoside
Minor criteria (any three): Vomiting, diarrhea, liver dysfuncGNR 10-14 Consider CVC removal for persistent positive cultures
tion, renal dysfunction, respiratory dysfunction (including
or clinical deterioration
CanrfWflspp. 14 RemoveCVCConsiderevaluationfordissemination
ARDS), CNS changes, mucous membrane inflammation
(hyperemia of the pharynx, tongue, and conjunctiva), and
Mycobacteria Unclear Remove catheter.lf peripheral blood cultures positive, may
muscle abnormalities (including myocarditis)
require more than 6 weeks of treatment
S. aureus more commonly associated with profuse diarrhea and
foreign body at site of infection. S. pyogenes more commonly
' Duration of therapy varies depending on presence of complications and specifi
c underlying
disease conditions. Optimal duration of therapy has not been established in chi
ldren. associated with localized soft-tissue infection (e.g., cellulitis,
Recommendations are extrapolated from adult data.
necrotizing fasciitis)
Additional Studies
- Fluconazole may be used if the organism is susceptible.
CBC with differential (leukocytosis or leukopenia, anemia, and
- Evaluation includes routine ophthalmologic exam. For persistently positive cultures, consider echocardiogram, abdomthrombocytopenia)
Blood culture positive for S. aureus in less than 5% of infected
inal ultrasound or CT, and head CT
patients
Cultures of foreign bodies and abscesses
Complications
Throat rapid antigen test and culture for S. pyogenes
Endocarditis, septic thrombosis, tunnel infections, and metastaS. aureus colonization screens can be performed but are not
tic seeding
necessary
If complications occur, antimicrobial duration may have to be
Increased ASO or antiDNAase B 4 to 6 weeks after infection
extended or changed
may confirm diagnosis
Other findings: Hyponatremia, hypokalemia, hypocakemia,
Toxic Shock Syndrome
hyperbilirubinemia (75%), elevated creatinine kinase (60%;
rhabdomyolysis)
Toxic shock syndrome (TSS): An acute febrile illness primarily
Urinanalysis: Sterile pyuria, myoglobinuria, red blood cell casts
caused by bacterial exotoxins. Patients with features of TSS
--------------------------------------- 12
118
Management
Supportive care, consider intensive care unit setting
Trauma-Related
- Search for localized infection, remove foreign bodies (e.g.,
tampons), send cultures.
Infections
Empiric therapy: (3-Lactam antibiotic (oxacillin, nafcillin or
cefazolin). Use vancomycin in place of (3-lactam if patient
Reza J. Daugherty, MD and Dennis R. Durbin, MD, MSCE
unstable or deteriorating
- Add clindamycin for severe disease because it may suppress
toxin synthesis.
- Adjust antimicrobial therapy based on culture results
Infections Following Trauma
Duration of antimicrobial therapy: 10 to 14 days. Oral therapy
once patient is stable
Epidemiology
Infection follows 1 % to 2% of lacerations and 20% to 40% of
Consider IVIG or corticosteroids for severe illness.
major trauma
Complications
Risk Factors
Multiorgan failure; death (less than '.) with S. aureus but 30%
to 70% with S. pyogenes]
Simple laceration infection: Soil contamination; more than 3 cm
length; foreign body ,
Organisms
Respiratory tract
Urinary system
Bloodstream
Surgical wound
S. aureus, P. aeruginasa
Soft tissue
S, aureus
Abdomen
S. aureus, L ml!
119
--------------------------------------- 13
Chapter
Ch. 2: Diagnostic Virology
TABLE 2-2 Properties and Classification of RNA Viruses
that Cause Human Disease
Diagnostic Virology
13
Virus
Family Name
Naked or
Common
Arenaviridae 50-300
Richard L. Hodinka, PhD
Examples
LCMV
Astroviridae 28
Naked
ss,(+)
Astrovirus
Classification and Properties of Viruses
Bunyaviridae 90-120
Enveloped ss(-),seg Sin Nombre virus,
Hantaan virus, Rift
(Tables 2-1 and 2-2)
Valley fever virus
Calidviridae 35-40
Naked
ss(+)
Norovirus,
calicivirus
TABLE 2-1 Properties and Classification of DNA Viruses
that Cause Human Disease
Coronaviridae 80-160
Enveloped ss(+)
SARS coronavirus,
^^mmmmmmmmmmm*m^^^MMMMMMBBBIi^MHMMIHBBB^^H^^memmmmmmmmmf ^^^^ ^
other coronaviruses
Virus
Naked or
Common
Filoviridae 80x790
Enveloped
Ebola virus,
Family Name
ss(-)
Size (nm) Enveloped Genome
Adenoviridae 70-90
Flaviviridae 40-50
Examples
Marburg virus
Naked
ds, linearAdenoviruses
Enveloped ss(+)
WNV,SLE virus,
Hepadnaviridae42
Herpesviridae 150-200
Parvoviridae 18-26
Poxviridae
Picornaviridae28-30
Naked
Naked
ss(+)
Enteroviruses,
virus, molluscum
rhinoviruses, HAV
contagiosum virus
Reoviridae
60-80
Naked
ds,seg
Rotavirus, Colorado
tick fever virus
Retroviridae 80-130
Enveloped ss(+),
HIV-1and2,HTLV-l
2 copies and II
Rhabdoviridae 70-85 x Enveloped
A variety of methods are available
130-380
of viral diseases (Table 2-3)
Togaviridae 60-70
Enveloped
Selection of assays to perform and
ssH
Rabies virus
for diagnosis and monitoring
ss(+)
Rubella virus, EEE
choice of specimen(s) to
virus, WEE virus,
collect for testing depend on the patient population and cliniVEE virus
cal situation and the intended use of the individual tests
--------------------------------------- 14
120
Cefazolin
--------------------------------------- 15
122
General
ling catheters; extremes of age; hyperglycemia
If infection present, obtain anaerobic and aerobic cultures. If
Etiology
fever, culture blood
Infections frequently polymicrobial
High-pressure irrigation, except for puncture wounds; debride
devitalized tissue
Wound infection: S. aureus, Pseudomonas aeruginosa, group A
Tetanus immunization as with other minor wounds. Role of
Streptococcus, Enterobacter spp., Klebsiella spp., Enterococcus
HIV prophylaxis unclear
spp., Acinetobacter spp.
Bloodstream infection: Coagulase-negative staphylococci, S.
Antibiotics
aureus, P. aeruginosa, group A Streptococcus, Klebsiella spp.
' Indications for antibiotic prophylaxis: 1) Puncture wounds, 2)
Pneumonia: Streptococcus pneumoniae, S. aureus (usually in
bites on face or hand, 3) cat bite, 4) devitalized tissue, 5) crush
ventilated patients)
injury, 6) immunocompromised patient
Urinary tract infections: P. aeruginosa, Escherichia coli (usually
Prophylactic antibiotic choice: Amoxicillin-clavulanate for
with urinary catheters)
5 days
Pathogenesis
- Alternate: TMP-SMX and clindamycin; cefotaxime; or
ceftriaxone
Significant burn injury leads to loss of normally protective skin
barrier, decreased production of interferon-y, immunoglobuRabies
lins, and phagocytes, poor opsonic and bactericidal activity, and
Dogs and cats (if dog/cat unable to be observed, consult local
public health official)
increased anergy to antigens
- If healthy, observe for 10 days: Immunize patient if animal
Colonization of burn wounds occurs by spread of normal skin
flora, translocation of gut flora, and nosocomial acquisition
develops rabies
- If signs/symptoms of rabies: Immunize patient plus rabies
History/Physical Examination
immune globulin (RIG)
Other animals: Consider sacrifice to test brain tissue for rabies
Local: Edema, erythema, discoloration, or necrosis around
- For high-risk animals, rabies immunization and RIG unless
wound edge; unexpectedly rapid eschar separation; hemoranimal tests negative
--------------------------------------- 16
124
1 I Co
or excision performed
- Empiric antibiotics for suspected infection: Gentamicin plus
Etiology
either ceftazidime, ticarcillin-clavulanate, imipenem, or
The major congenital infections are encompassed in the acronym
ciprofloxacin plus an aminoglycoside
TORCHES
Parenteral glutamine may decrease gram-negative sepsis; IVIG
- Toxoplasmosis, Others, Rubella, Cytomegalovirus, Herpes
with unproven but potential benefit; interferon-y not shown to
simplex virus, Enterovirus, Syphilis
reduce infection
- "Others": Listeria monocytogenes, varicella, human immunodeficiency virus (HIV), parvovirus, enteroviruses
Complications
Increased hospitalization length, morbidity, and mortality;
Pathogenesis
worse cosmetic outcome
Fetal infection occurs by 1) transplacental passage (hematogenous spread; most common), 2) invasion through intact, damaged, or ruptured amniotic membranes, 3) exposure to infected
maternal genital tract
Additional Studies
Chorionic villus, amniotic fluid, and cord blood sampling allow
in utero diagnosis
Blood: IgM (toxoplasma, rubella), RPR (syphilis), hepatitis B
surface antigen
CSF: DNA PCR (enterovirus, HSV), Venereal Disease Research
Laboratory (VDRL; syphilis)
Skin lesions: DFA (HSV, varicella), dark field (syphilis)
Viral culture: Conjunctiva (HSV), mouth (HSV, enterovirus),
rectum (HSV, enterovirus), urine (CMV)
Radiography of long bones (rubella, syphilis) or head CT (CMV,
toxoplasmosis)
Ophthalmologic exam (toxoplasmosis, rubella, CMV, HSV,
syphilis, varicella)
Hearing screen (rubella, CMV, toxoplasmosis)
Other studies: Liver function tests, CBC
125
--------------------------------------- 17
126
P
M
Risk Factors
History/Physical Examination (also see "Risk Factors")
TD risk factors including HIV infection and multiple anony-
--------------------------------------- 18
128
C
I
Su
Con
Ep
Ri
--------------------------------------- 19
130
Et
Pathogenesis
Additional Studies
Acquired via transplacental, intrapartum (passage through
Radiography: Osteitis on long-bone films ("celery stalking")
infected maternal genital tract), and postpartum (infected
Neuroimaging: Intracranial calcifications on CT/MRI
breast milk or blood transfusion) transmission
Ophthalmologic exam: Cataract, glaucoma, retinopathy
rst-trimester maternal primary infection most likely to result
Hearing screen: Sensorineural hearing loss
in fetal sequelae
Blood: Hyperbilirubinemia, transaminitis, hemolysis, thromboedilection of virus for CNS, reticuloendothelial system, and
cytopenia
Fi
Pr
liver
Diagnosis
History/Physical Examination
Virus-specific IgM from fetal or neonatal blood
egnancy complicated by premature delivery or symmetric
Culture of virus from the amniotic fluid, urine, blood, CSF,
Pr
and/or nasopharynx
IUGR
If symptomatic, findings include petechiae or purpura (75%),
Stable or increasing rubella-specific IgG over the first year of
jaundice (65%), hepatosplenomegaly (60%), microcephaly
life
(50%), and hypotonia (25%)
Management
No antiviral treatment available; infected neonates require
ditional Studies
Ad
He
Ma
--------------------------------------- 20
132
Po
lesions (rare)
50% to 90% of surviving neonates with symptomatic infection
have CNS impairment, including mental retardation, cerebral
story
palsy, and visual abnormalities
Hi
Kn
own maternal infection or vesicular lesions at delivery
Progressive hearing loss in 50% of patients with symptomatic
to 80% of infected infants born to asymptomatic mothers
infection and 5% of patients with asymptomatic infection
60%
Ph
ysical Examination
Neonatal Herpes Simplex Virus Infection
set varies from birth to 3 weeks of life (typically at 11 to 17
days) but 9% present within 24 hours of birth. Disseminated
On
c
Co
C
NS disease with or without vesicles: Lethargy, irritability
Epidemiology
eizures, vesicles (60%)
Neonatal infection in 1 in 3000 to 20,000 live births: 5% conseminated disease (involves multiple organs including CNS
s
Dis
A
dditional Studies
Risk Factors
iography: Pneumonia begins centrally and involves entire
Rad
lung in 1 to 3 days
Symptomatic primary infection with vaginal delivery; Prolonged
: Elevated protein, low glucose, lymphocytic pleocytosis
membrane rupture (more than 4 hours); prematurity; instru-
CSF
Cul
--------------------------------------- 21
134
Management
Acyclovir:
- Skin/eye/mucous membrane disease: 60 mg/kg/d IV divided
into three doses for 14 days
- CNS/disseminated disease: 60 mg/kg/d IV divided into
three doses for 21 days
lizabeth R. Alpern, MD, MSCE and Samir S.Shah, MD
- Consider suppressive acyclovir for those with recurrent skin
lesions
Symptomatic neonate: Cultures and CSF PCR immediately, IV
rile Neonate
acyclovir
Vaginal birth (primary infection): Cultures and CSF PCR at 24
er (38.0C or higher) in a well-appearing infant (0 to 60
to 48 hours, acyclovir
days of age) without identifiable source of infection. Infant is
Vaginal birth (recurrent infection): Surface cultures at 24 to 48
t risk for occult serious bacterial infections (SBI)
hours, IV acyclovir for positive cultures or onset of symptoms
Feb
Fev
o
1
Unt
Exp
to ill contacts
Disseminated disease: 30% mortality but fewer than 20% of
ative immune compromised state of young infants
survivors have neurologic sequelae
Rel
E
tiology
M
ost common pathogens: Escherichia coli, Klebsiella species,
Streptococcus pneumoniae, group B Streptococcus, Staphylococcus
aureus, Enterococcus spp., Listeria monocytogenes
H
istory/Physical Examination
V
ague or nonspecific signs and symptoms of illness (may present with just an isolated fever)
F
ever, irritability, lethargy, poor feeding, emesis, diarrhea, jaundice, rash
S
earch for findings that suggest a likely cause (see "Differential
Diagnosis")
L
ack of ill appearance does not rule out SBI in neonates
A
dditional Studies
N
egative screen (Philadelphia protocol) indicates low risk for
SBI (Baker et al):
135
--------------------------------------- 22
136
-
Gram stain
Etiology
- Normal CXR, stool smear without WBCs (perform if specific signs)
Common: S. pneumoniae
Uncommon: Salmonella spp., group A Streptococcus, Moraxella
Positive screen (higher risk for SBI) if any one or more of above
catarrhalis
criteria not met
' H. infiuenzae type B rare since introduction of HIB vaccine
Rate of S. pneumoniae infection may be lowered by conjugate
Differential Diagnosis
vaccines
Abscess, cellulitis, bacteremia, bacterial meningitis, bacterial
enteritis, pneumonia, septic arthritis, osteomyelitis, urinary
History/Physical Examination
tract infection, aseptic meningitis, HSV encephalitis, bronchiDetermine risk factors (age, immunization status)
olitis, and nonbacterial gastroenteritis
Assess for findings that exclude patient from OB diagnosis: 1)
Underlying condition (e.g., primary immune deficiency, sickle
Management
cell); 2) focal bacterial infection (e.g., meningitis, osteomyelitis,
pneumonia)
Criteria: Age 0 to 60 days and fever greater than 38.0C without identifiable source
Additional Studies
Evaluation: CBC, UA, and blood, urine, and CSF cultures. Consider CXR if hypoxia or respiratory findings. Consider stool
Consider other studies to determine focal infection (e.g., urine
culture, CXR)
culture if diarrhea
Blood culture is diagnostic but contamination rate is 2%
Specific Management:
- Age 0 to 28 days: All infants require admission and IV ampiWhite blood count or C-reactive protein used by some to idencillin and gentamicin or cefotaxime while awaiting culture
tify those at higher risk
results
Management
- Age 29 to 60 days: "Negative screen" permits discharge without antibiotics. Reevaluate in 24 hours
Careful exam and follow-up are mandatory in all patients
- Age 29 to 60 days: "Positive screen" requires admission and
Some experts advocate blood culture
osteomyelitis
Febrile Infant
Fever of Unknown Origin
Occult bacteremia (OB) is the presence of pathogenic bacteria
in the blood of a healthy, well-appearing, febrile (T > 39.0C)
ever of unknown origin (FUO) indicates 1) prolonged fever
child without a focal bacterial source of infection. Important
(more than 2 weeks); 2) documented temperature greater than
because of risk of progression to focal infection (e.g., meningitis)
38.3C on multiple occasions; and 3) uncertain cause
--------------------------------------- 23
138
139
Culture (bacterial/viral)
- Less common: Tuberculosis; cat-scratch disease; infectious
Ova/parasite testing
mononucleosis; Lyme disease; Rocky Mountain spotted
Radio logic
CXR
Sinus O
fever; ehrlichiosis; malaria; dental abscess; brain abscess;
Upper GI barium study
endocarditis; HIV
Abdominal ultrasound
- Rare: Q fever, brucellosis, tularemia, leptospirosis; parvovirus
MRI of pelvis, spine, or other
Bone or gallium scan
B19; histoplasmosis; blastomycosis; coccidioidomycosis,
syphilis
Echocardiogram
Miscellaneous Tuberculin skin test
Ophthalmologic examination
Pathogenesis
Nasal aspirate for rapid viralLP
antigen detection
Temperature normally varies with peak in early evening and
nadir in early morning
Throat culture
History/Physical Examination
deficiency (see Chapter 22)
Exposure to animals: Includes rodents and farm animals; unpasInitial serologies: EBV,CMV,streptococcal enzymes, antinudear antibodies.
teurized milk; and household contacts with occupational
' Second-line strategies: Hepatitis A, B,C, tularemia, brucellosis, leptospir
osis, Rocky Mountain
exposure
spotted fever, ehrlichiosis, Q fever (if relevant exposures).
Tick or flea bites (e.g., tularemia, brucellosis, Lyme)
Adapted from CalelloDP.ShahSS.The child with fever of unknown origin, fediatr C
ase Rev
Travel history: Includes prophylactic measures (e.g., malaria
2002;2:226-239.
prophylaxis) and close contacts who have traveled
Medications, antecedent illness or trauma, family history (e.g.,
immune deficiency)
Search for findings that suggest a likely cause (see "Etiology"
Management
and "Differential Diagnosis")
Careful and repeated history and physical may reveal diagnoCheck growth parameters, skin findings, bone tenderness, gait
sis. "Shotgun" approach to evaluation rarely useful but certain
and muscle mass
initial studies (Table 18-1) may provide insight
Additional Studies
Complications
See Table 18-1 for suggested evaluation. Not every patient
Related to cause of FUO; iatrogenic complications during overneeds every test
zealous evaluation
Differential Diagnosis
Noninfectious causes: Systemic juvenile rheumatoid arthritis
Periodic Fever Syndromes
(JRA); systemic lupus erythematosus; sarcoidosis; vasculitis;
malignancy; Kawasaki; inflammatory bowel disease; drug or
Recurrent fevers that last from a few days to a few weeks,
central fever; periodic fever syndrome; factitious fever
separated by symptom-free intervals of variable duration
--------------------------------------- 24
14
fluorescein-labeled
monoclonal antibodies
Serology Viral Ab Mainly immunofluorescenceModerate,-1-3 h
Immunologic Tests
enzyme immunoassays,anlodw
latex agglutination to detect
Fluorescein-labeled Moderate 1-3h
virus-specific IgG or IgM
fluorescence antigemonoclonanl antibodies bind
antibody responses
to viral antigens within
Genotypic Viral
Sequencing-based moleculaHigrh Genotypic
infected cells of a clinical
and pheno- mutationtestss identify specific gene 1-2 d;
specimen
typic assays or genetimutationcs leading to drug Phenotypic
Immunoassay Viral Monoclonal antibodieModerats e 20min-2h
Immuno- Viral
2-6 wk
sectioned specimens
utility. Tests are slow, relatively insensitive, cumbersome to
(Continued)
perform, and expensive. However, assay format is well suited
for detecting human papillomaviruses
--------------------------------------- 25
140
<2Gyr"
<1yr
<20yr
of onset
Management
Duration of 4-5 d
See Table 18-2.
episode
1-2 d
3-7 d
>7d
Frequency of 21-42d
7-28 d*
14-28 d*
None
Complications
recurrence
PFAPA: Resolves within 5 years of onset in 40%; no long-term
Symptoms StomatitisPeritoniti, s Cervical Arthralgias,
inhibitor in>1QOIU/mLtypelTN; F
serosal fluidselevated IgAreceptor
(80%)
Therapy Single-dosColchicine e
Epidemiology
prednisone(daily) .
None
Corticosteroids;
etanercept
at symptom
(binds TNF-oc)
More than 20% of travelers report illness associated with travel
onset;
3% of international travelers are affected by fevers; malaria is
prophylactic
most common cause
cimetidine
Onset younger than 10 years in 50%.
Risk Factors
'Often unpredictable.
Increased risk with visits to family/friends or "adventure" tours
'fAF.familial mediterranean fever
Adapted from DrenthJPH.ranDerMeerJWM. Hereditary periodic faet.N EngU Mat
Etiology/Pathogenesis
2001;345:1748-1757.
See Table 18-3.
--------------------------------------- 26
142
Organism
Associated
Immunizations; antimalarial chemoprophylaxis
or disease
Transmission
Incubation
Symptoms
Malaria
Mosquito
Additional Studies
findings; jaundice;
Determine tests as indicated by history, physical examination,
HSM
time course of illness
Consider: Peripheral blood for malaria, CBC, liver function
Dengue
Mosquito
<14d
Headache; myalgias;
tests, urinalysis, blood culture, stool culture and ova/parasite
adenopathy;rash;
examination, CXR, tuberculin skin test
splenomegaly
Rickettsia
Tick or mite <14d
Headache, myalgia
Specific serologic assays: Dengue virus, rickettsiae, schistosomes, leptospira, HIV
Bacterial enteritiContaminatesd<14d
food/water
Undifferentiated
fever
Headache; myalgias;
hemorrhage;
itinerary (e.g., sinusitis)
conjunctiva!
suffusion; jaundice
Management
Typhoid fever Contaminated
<14dto6wk
CNS findings
food/water
Management options must be tailored to specific disease
TrypanosomiasiTsetsse fly
<14d
CMS findings;
process
splenomegaly
Test for malaria in all patients returning from malaria endemic
Viral hemorrhagiMosquitoc; direct/<21d
Hemorrhage;
area with fever
fever (see
airborne
jaundice;
Chapter 24)
splenomegaly
Influenza
Direct/airborne<14d
Kawasaki Syndrome
Hepatitis A or EContaminated 14dto6wk
Respiratory findings
Jaundice;
food/water
hepatomegaly
Small- and medium-vessel vasculitis (also termed mucocutaSchistosomiasisCercariae in fresh4-8 wk
Headache; myalgias;
neous lymph node syndrome)
water
arthralgias; cough;
diarrhea; HSM
Q fever
Inhalation of 14dto6wk
Respiratory findings
Epidemiology
animal source
Median age, 2 years; 80% of patients younger than 5 years; only
5% older than 10 years
Tuberculosis Inhalation
--------------------------------------- 27
144
aspirin-allergic patients
- Cervical adenopathy: Greater than 1.5 cm; usually unilateral;
Corticosteroid therapy controversial but under study
absent in 50%
Repeat echocardiogram 2 weeks after diagnosis and 1 month
- Extremity changes: Palmar erythema; swollen hands/feet;
later
desquamation (2 to 3 weeks)
- Detection of aneurysm requires continued cardiology
- Polymorphous rash: Usually begins 3 to 5 days after fever;
follow-up
classically at groin/buttocks
Complications
Associated features: Aseptic meningitis (25% to 40% of patients
undergoing LP); uveitis (80%); acute myocarditis (30%); diarCoronary artery aneurysms: Small (less than 8 mm) aneurysms
rhea (25% to 50%); gallbladder hydrops (10%); hepatitis (50%);
regress; larger ones often persist and may rupture or develop
pancreatitis; urethritis (50%); arthralgias/arthritis (33%)
stenosis or thrombosis; overall mortality less than 0.3%
Incomplete or atypical Kawasaki cases do not fulfill above criteria but still may develop coronary aneurysms
Additional Studies
WBC count: 95% more than 10,000/mm
15,000/mm 3
Hemoglobin: 75% less than two standard deviations below the
mean
Platelets: Increase during second week; usually increase to
more than 750,000/mm 3
ESR: Elevated in more than 90%
Urinalysis: Sterile pyuria due to urethritis may be missed by
bladder catheterization; therefore, fresh void specimen preferred.
Echocardiogram: Detects coronary aneurysms; usually present
at 10 to 21 days
Differential Diagnosis
Infectious: Measles; scarlet fever; Epstein-Barr virus; adenovirus; enterovirus; parvovirus B19; S. aureus toxin-mediated
disease; Rocky Mountain spotted fever
Allergic/rheumatologic: Drug reaction; Stevens-Johnson syn-
--------------------------------------- 28
Ch. 19: Fever and Rash
147
Sips/Symptoms/Lab Data
AdmittotheKU.stablzewith IF
antibiotic if appropriate
positive streptococcal antigen test
Petechiae, caused by extravasation of red blood cells, are nonDischarge with foltow-up in 12 to INormaFl WBC, band count less than
blanching erythematous macular skin lesions 1 mm or greater
24 h.Presumptiveantibiotic
500/mm 3,ANC 1500-9000/mm 3,
in size
Febrile infants and children with a petechial rash raise the contherapy (IM ceftriaxone)
normal PT,and no progression of rash
cern of invasive bacterial infection caused by Neisseria meningiAdmission with completion of IAnF y abnormal laboratory data (as above)
lumbar puncture and
or progression of rash
tidis or other organisms
intravenous fluids/antibiotics
Epidemiology
2% to 20% of children with fever and petechiae have invasive
infection; risk highest if under 2 years old or ill appearing
Additional Studies
Well-appearing children with petechiae and normal WBC
Etiology
count, band count, and prothrombin time are at lower risk for
Bacterial: N. meningitidis, Streptococcus pneumonias, Haemoinvasive disease
philus influenzae type B, Escherichia coli
Viral: Influenza, parainfluenza,
Management (Table 19-1)
virus (EBV), dengue, adenovirus,
No consensus on management of
rotavirus
fever and petechiae
Other infections: Rocky Mountain
enteroviruses, Epstein-Barr
respiratory syncytial virus,
well-appearing children with
spotted fever (RMSF),
--------------------------------------- 29
148
--------------------------------------- 30
150
151
--------------------------------------- 31
152
Enterovi
and trunk
(HHV-6or7)
trunk
acrodermatitis)buttocks
rnfantum
i Additional Studies
In well-appearing children with fever and exanthema, a careful
history and examination often leads to the correct diagnosis
without the need for further studies
Measles: Serology, measles-specific IgM
Rubella: Serology, rubella-specific IgM; culture from nasal
specimen
Human herpes virus 6 (HHV-6): Testing not available, commercial antibody and PCR reaction assays in development
Parvovirus B19: Serology, parvovirus-specific IgM; PCR in
immunocompromised
--------------------------------------- 32
Ch. 20: Infections in Children with Cancer
155
Infections
in Children
Pathogenesis
Disruption of skin/mucous membranes 2 to therapy, surgery,
indwelling catheters
with Cancer
Depletion of host defense cells (neutrophils, lymphocytes,
others)
AnneF.Reilly,MD,MPH
History/Physical Examination
Recent chemotherapy (to judge expected period of neutropenia)
Fever and Neutropenia
Any complaint could be important: Cough, headache, diarrhea, dysuria, rash
Fever in a child with cancer may be the first sign of serious
nfection may not be obvious when the ANC is low; neuinvasive infection
trophils are critical to the inflammatory response. Tenderness
Fever: Temperature greater than 38.3C even once, or 38.0C
y be the only localizing sign of infection
or higher for more than 1 hour
Careful examination of entire body; examine skin for rashes,
Neutropenia: Absolute neutrophil count (ANC) less than
ulcers, vesicles, erythema
500/mm 3, or less than 1000 mm3 and falling
Additional Studies
Epidemiology
BC, chemistries, urinalysis (may not see pyuria in a neutropenic patient)
A definite source of infection is found in 20% to 40% of febrile
lood cultures, including samples from each lumen of a central
neutropenic patients
venous catheter
Other cultures as indicated: Urine, stool, CSF, oral or skin lesions
Risk Factors
XR: Consider in all patients, particularly with respiratory
Low risk of serious infection: 1) ANC 100 cells/mm3 or more;
symptoms
2) neutropenia expected to last less than 10 days; 3) normal
CXR; 4) no other significant comorbidities
Differential Diagnosis
High risk of serious infection: All patients not at low risk
ommon sites of infection in febrile neutropenic patients
include bloodstream; skin/soft tissue; mouth/oropharynx; gas Etiology
trointestinal (GI) tract; lungs; sinuses
Infectious:
anagement
ma
- Bacteria:
- Gram positive (most common): Coagulase-negative staAntibiotics: Prompt empiric broad-spectrum antimicrobial
phylococci, Staphylococcus aureus, viridans streptococci,
therapy
enterococci, Clostridium difficile
Potential Regimens
- Gram negative: Escherichia coli, Klebsiella, Enterobacter,
Potential regimens may vary depending on institution:
Pseudomonas spp., anaerobes
- Fungi: Candida spp., Aspergillus spp., Pneumocystis carinii,
Monotherapy: Ceftazidime or cefepime or carbapenems
cryptococci
(imipenem/cilastatin, meropenem)
- Viruses: Herpes simplex virus (HSV), varicella-zoster virus
Duotherapy: Aminoglycoside (gentamicin, tobramycin, or ami(VZV), cytomegalovirus (CMV), Epstein-Barr virus (EBV],
kacin) plus ticarcillin-clavulanic acid or piperacillin-tazobactam
respiratory syncytial virus (RSV], adenovirus, influenza virus,
or cefepime or ceftazidime or carbapenem
parainfluenza virus
Add vancomycin when resistant organisms are common, parNoninfectious: Medications; underlying malignancy; blood
ticularly viridans group streptococci. Vancomycin can be discontinued after 24 to 48 hours if no such organism is found on
products
culture
154
--------------------------------------- 33
156
infections
Antiviral drugs when appropriate: 1) Acyclovir (HSV or VZV);
2) ribavirin (RSV); 3) amantadine, oseltamivir, or others
(influenza virus)
Granulocyte transfusions and colony-stimulating factors are
Additional Studies
not routinely recommended. May be used in neutropenic
Aspirate or biopsy of representative lesions, with culture and
patients with severe fungal infection, or uncontrolled bacterial
infection despite appropriate antibiotic therapy
pathology if possible
Vesicles scraped at base for direct fluorescent antibody testing
for VZV or HSV
Skin Infections
Blood cultures when fever present; chemistries for hepatic or
renal involvement
I Etiology (Table 20-1)/Pathogenesis
Management
Common skin flora gain access to skin via breaks caused by
Systemic antimicrobial therapy appropriate to the infecting
catheters, wounds, and chemotherapy-induced lesions such as
organism indicated. Treat intravenously if significant immunooral ulcers
--------------------------------------- 34
158
159
C
--------------------------------------- 35
16
lected and transported in such a manner as to ensure the stadetecting viral-specific antibody responses. Detection of virusbility and amplification of the nucleic acids. This is particularly
specific IgM or a seroconversion from a negative to a positive
true when collecting and transporting specimens to detect
IgG antibody response can be diagnotic of primary infection.
RNA viruses; RNA is a very unstable molecule and is
Detection of virus-specific IgG in a single serum specimen
extremely susceptible to degradation by RNases that are ubiqindicates past exposure or vaccination. Negative antibody
uitous in the environment.
titers may exclude viral infection.
For serological assays, blood should be collected without the
use of anticoagulants or preservatives. A single serum specimen
Specimen Collecting and Handling
is required to determine the immune status of an individual or
for Viral Diagnosis
for the detection of virus-specific IgM antibody. With few
exceptions, paired serum specimens, collected 10-14 days
Collect specimens as close to clinical onset as possible. Acute
apart, are required for the diagnosis of current or recent viral
viral infections are self-limited and cleared within the first 5 to
infections when specimens are tested for virus-specific IgG
10 days of illness. Therefore, nothing is gained by a delay in
antibody.
taking a specimen. However, duration of viral shedding varies
When submitting specimens to the laboratory, the specimen
depending on the virus, the host immune status, the anatomic
container should be labeled with the patient's full name, the
site or source of the specimen, and whether there is systemic
medical record number or other unique identifier, and date and
or local involvement
time of collection. Each specimen should be accompanied by a
Virus recovery may be enhanced by collecting multiple specirequisition slip containing the same information as on the
mens from different body sites
specimen as well as the suspected clinical diagnosis.
Transport specimens to the laboratory as quickly as possible
after collection because some viruses, particularly those with
--------------------------------------- 36
160
161
Co
--------------------------------------- 37
Ch. 21: Human Immunodeficiency Virus Infection
Human
163
The CD4 cell is the key target cell. Though all arms of the
I Immunodeficiency
immune system are affected, the degree of immune dysfunction can be staged by measurement of the T-cell subset of CD4
Virus Infection
percentage and number
History
Richard M.Rutstein,MD
Inquire about risk factors in the parents (substance abuse,
transfusions, STDs)
Inquire about risk factors in the patient (sexual activity/abuse,
HIV
substance abuse)
Epidemic continues despite recent decreases in mother-child
nquire about HIV testing in the parents
transmission (MCT) and mortality/morbidity in areas with
Frequent invasive infections: pneumonia, arthritis, bacteremia
access to antiretroviral therapy (ART)
Chronic or recurrent thrush
Worldwide, approximately 1500 children infected daily. Most
nexplained hepatitis, chronic diarrhea, poor growth
(more than 90%) have limited ART access
Physical Examination
Epidemiology
Ch
Wh
HI
--------------------------------------- 38
164
Di
--------------------------------------- 39
166
167
HI
An
months)
Stavudine (M)a
- After infancy, risk related to CD4% and counts. Require proDidanosine(ddl)"
phylaxis if CD4% is less than 15% to 20%, absolute CD4
Zalcitabine(ddC)
less than 500 cells/mm3 (younger than 5 years) or less than
Tenofovir
200 cells/mm3 (older than 5 years)
Abacavir"
- Think P. carinii in infant younger than 1 year, with tachypFTC
nea, hypoxemia, quiet rales (or no adventitial findings),
Nonnudeoside RTI
CXR with interstitial/alveolar infiltrate. Elevated serum
Nevirapine"
LDH reflects lung injury
Delavirdine
- Diagnosis: Identification of organism on histologic smears of
Efavirenz"
lung fluid (obtained by BAL or aspiration), gives positive
silver stain
Protease Inhibitors
- Treatment is with high-dose IV TMP-SMX with or without
Ritonavit"
adjunctive steroids for 3 weeks
Indinavir
- Mortality close to 50% for first episode in infancy
Saquinavir
- Prophylaxis: TMP-SMX, 150 mg/m2/d, 3 days/week. For
Nelfinavir
Lopinavir/ritonavir"
patients allergic to TMP/SMX, use aerosolized pentamidine,
Arnprenavir*
or oral dapsone or atavoquone
Atazanavir
Progressive encephalopathy (PE)
- Occurred in up to 25% of patients prior to advent of threeFusion Inhibitors
or four-drug combination therapy
Enfuvirtide (T-20)
- Onset 9 to 18 months of age, rare after age 3 years
- Key hallmark of disease is loss of previously acquired
Nudeotide RTI
skills
Tenofovir
- May be rapid downhill progression, with death within 6 to
12 months of diagnosis. Some patients have a plateau phase
As of May 1,2004,
" Child-friendly formulation available as liquid, powder.or capsules that may b
e opened onto food.without further developmental regression
--------------------------------------- 40
168
--------------------------------------- 41
Chapter
Ch.22: Inherited Immune Deficiencies
Inherited Immune
BOX 22-1 Categories of Primary Immune Deficiencies
Humoral Deficiency (B cell)
Deficiencies
Transient hypogammaglobulinemia of infancy"
X-linked agammaglobulinemia"
Common variable immunodeficiency"
Timothy Andrews, MD and Elena Elizabeth Perez, MD, PhD
IgA deficiency"
IgG subclass deficiency
Hyper-IgM (recessive form)
Evaluation of Suspected Primary ln? unqdeficiency
Cellular Immune Deficiency (T cell)
Inherited diseases of immune system function (single-gene
lnterferon-YlL-12axis
Autoimmune polyglandular syndrome type 1
defect or polygenic); more than 70 primary diseases known
Combined Immune Deficiency (T cell and B cell)
Epidemiology
171
--------------------------------------- 42
172
--------------------------------------- 43
174
explants
In many with isolated IgA deficiency disease is asymptomatic;
others develop recurrent sinopulmonary infections
Wiskott-Aldrich Syndrome
Associated with atopy and autoimmune disorders
Triad of immunodeficiency, eczema, and thrombocytopenia
Diagnosis: Serum IgA concentration less than 7 mg/dL
(platelets also small and defective)
Risk for developing anti-IgA antibodies from blood products
X-linked recessive inheritance; defect in WASP gene (product
and subsequent anaphylaxis
important for actin polymerization)
Increased susceptibility to infection (S. pneumonias, P. carinii,
Cellular and Combined Immune Deficiency
herpes virus)
Poor antibody responses to polysaccharides
Severe Combined Immunodeficiency (SCID)
Usual presentation in infancy with prolonged bleeding (cir' Category of diseases resulting in abnormal lymphocyte number
cumcision, diarrhea, or bruising)
and function
Diagnosis: Specialized genetic testing to confirm diagnosis
May be X-linked or autosomal recessive. Occurs in approxiHuman leukocyte antigen-identical sibling bone marrow
mately 1 in 100,000 live births
transplants may be indicated
Manifestations include failure to thrive, recurrent/chronic respiratory infection, opportunistic or fungal infection
Graft versus host disease rash from maternal T cells in some cases
Phagocyte Disorders
Initial management: Strict isolation, IVIG, no live vaccines,
only irradiated CMV-negative blood products if necessary,
Neutrophil Disorders (Table 22-2)
trimethoprim-sulfamethoxazole (TMP-SMX) prophylaxis,
* Diminished neutrophil number or function (chemotaxis,
search for bone marrow or stem cell donor
phagocytosis, oxidative burst)
--------------------------------------- 44
176
Kostmann syndrome
--------------------------------------- 45
Ch. 23: Infections in Other Immunocompromised Hosts
Infections in Other
179
lmmunocompromised
S TABLE 23-1 Etiology of Common Infections in Children
3
1i_ _.
th Sickle Cell Disease
Hosts
Syndrome
Common
Less Common
Bacteremia
S. pneumoniae
H. influenzae
Marian G. Michaels, MD, MPH and Shruti M. Phadke, MD
Salmonella species
Candida species"
Coagulase-negative
GNR
staphylococci"
a-Hemolytic streptococci
5. aureus
Infections in Sickle Cejl Disease
Neisseria meningitidis
wi
S. pneumoniae
N/A
- Abnormal red blood cell structure and life span
M. pneumoniae
Increased risk for severe infections largely due to functional
C pneumoniae
Other
asplenia
--------------------------------------- 46
Ch.3: Antimicrobial Agents
19
--------------------------------------- 47
180
181
Ep
Su
- Surgical site
of age
- Urinary tract
- Vaccination against bacterial infections with routine child- Pneumonia
hood immunizations. Especially important: 1) S. pneumoniae
Candida spp.
(conjugate followed by polysaccharide after 2 years of age);
Herpes simplex reactivation
2) H. influenzae type B; 3) Neisseria meningitidis
Nosocomial infections
' Aggressive evaluation of fevers for infectious cause
Middle (1-12 months)
Aggressive treatment of infections with antibiotics
Donor-associated/opportunistic
Bone marrow transplantation available for those with severe
- Cytomegalovirus
illness and frequent infections
- Epstein-Barr virus (PTLD)
- Pneumocystis pneumonia
- Nocardia
Infections in Solid Organ Transplant Recipients
- Toxoplasmagondi!
Infections are a major cause of morbidity and mortality after
Late (> 12 months)
transplantation
Community acquired
The transplanted organ is often a major focus for the site of
Bacterial (chronic rejection)
infection
Aspefgillui or other fungi
- Urinary tract infections or pyelonephritis after renal transEpstein-Barr virus (PTLD)"
plantation
- Cholangitis and hepatitis after liver transplantation
EBV/PTLD ongoing risk in late period although less than in middle period.
- Pneumonia after lung transplantation
--------------------------------------- 48
182
Ep
In
Ge
Et
- Blood culture
Chronic infection/inflammation of the lower respiratory tract
- Viral cultures and relevant tests for likely viruses (see
and sinuses
"Diagnostic Virology")
- S. aureus, nontypeable H. influenzae, Pseudomonas aeruginosa
--------------------------------------- 49
184
185
cepacia)
Antibiotics to treat chronic airway infection and inflammation
- Oral, inhaled, or intravenous routes
- Aspergillus: Allergic bronchopulmonary aspergillosis (ABPA)
- Antipseudomonal treatment requires a combination of
active antibiotic groups (e.g., (5-lactam and aminoglycoside)
Pathogenesis
bilization of viscous, inspissate secretions: 1) Airway clearAbnormal CFTR structure/function leads to increased viscosance techniques; 2) inhaled mucus-thinning agents
ity of secretions, particularly in the exocrine pancreas and
Goals of therapy: Control chronic infection and prevent prolungs
gression of lung disease
Mechanism of lung disease: 1) Inspissation of secretions; 2)
bronchial obstruction; 3) chronic suppurative infection; 4)
Complications
progressive airways inflammation; 5) bronchiectasis
Mo
Related to infection
- Atelectasis from impacted mucous secretions
History
- Hemoptysis can result from chronic inflammation and the
Community-acquired viral respiratory infections trigger puldevelopment of tortuous collateral vessels of the bronchial
monary exacerbations
arteries
Increasing fatigue, worsening exercise tolerance
- Other allergic/inflammatory processes (e.g., ABPA)
Worsening cough, increasing sputum production
lated to frequent use of antibiotics (e.g., drug-resistant
Signs and symptoms of worsened malabsorption (e.g., bulky,
pathogens, renal and audiologic dysfunction resulting from fregreasy, malodorous stools and weight loss)
quent aminoglycoside use)
Related to progressive airways obstruction (e.g., pneumothoPhysical Examination
rax can result with rupture of blebs; respiratory failure and cor
General appearance, vital signs, and growth parameters
pulmonale in advanced stages of lung disease)
- Respiratory rate and oxyhemoglobin saturation
- Weight loss with pulmonary exacerbations and pneumonia
Signs of respiratory distress and dyspnea
- Nasal flaring and retractions (intercostal and abdominal)
- Use of accessory muscles of respiration
Contour and shape of thorax
- Barrel chest in patients with chronic lung disease results
from progressive smaller airways obstruction
Palpation and percussion of hyperinflated lungs
Auscultation (air entry; prolongation of expiratory phase; fine,
end-inspiratory crackles)
Other pertinent physical findings: 1) Nasal polyps are present
in 10% to 15% of patients; 2) sinus tenderness with associated
symptoms; 3) hepatosplenomegaly resulting from liver cirrhosis and portal hypertension; 4) digital clubbing
Additional Studies
Sputum culture for bacterial pathogens with antibiotic susceptibilities
Pulmonary function tests for changes in spirometric parameters
Re
--------------------------------------- 50
Chapter
Ch. 24: Biowarfare Agents
187
Gastrointestinal
Initially fever, nausea, anorexia then abdominal pain, hematemesis, bloody diarrhea
Biowarfare Agents
Oropharyngeal
Neck swelling from lymphadenopathy can compromise airway
Throat pain, dysphagia, and ulcers at base of tongue
Andrew L.Garrett, MD and Fred M. Henretig, MD
Additional Studies
Regardless of your level of experience, you may be the first
Routine culture of blood (inhalational, GI disease), CSF (meninperson to suspect an exposure to a biologic warfare (BW) agent.
gitis), or lesion (cutaneous) may demonstrate B. anthracis
Your response to such a situation may determine whether the
Toxin detection assay in cases of bacteremia may be helpful
incident is controlled promp tly or whether it evolves into a
CXR may show widened mediastinum, pleural effusion, or infillarge-scale epidemiologic catastrophe.
trate
The most likely BW agents are discussed below.
Culture of nasal swabs used for epidemiologic data collection
but not for diagnosis
Anthrax
Differential Diagnosis
Bacillus anthracis: Gram-positive, encapsulated, aerobic, sporeCutaneous: Tularemia, bacterial skin infection, brown recluse
forming rod
spider bite
Primarily a zoonotic pathogen in herbivores
Inhalational: Dissecting aortic aneurysm, superior vena cava
syndrome
Pathogenesis
--------------------------------------- 51
188
flo
hoidal form
Identification of a coccobacillus in lymph node aspirate,
CXR: Typical or interstitial pneumonia possibly with pleural
sputum, blood, or CSF
effusion
Polymerase chain reaction (PCR) useful from swabs of ulcers
Organism grows slowly in routine culture medium, so enzymeBacteria may be cultured from blood, lesion swabs, and
linked immunosorbent assay Fl Y. pestis antigen detection confirms the diagnosis
sputum, but require specific media and precautions given risk
of spread of tularemia
Differential Diagnosis
Antibodies present 11 to 21 days after onset of symptoms.
Community-acquired pneumonia, hantavirus pulmonary synDifferential Diagnosis
drome, rickettsiosis, meningococcemia, pneumonic plague,
ricin or staphylococcal enterotoxin B
Severe pulmonary infections: Mycoplasma, plague
Typhoidal illnesses: Malaria, salmonella, rickettsia
Management
Gentamicin or streptomycin. In meningitis, consider adding
Management
chloramphenicol
Streptomycin or gentamicin for 7 to 14 days
--------------------------------------- 52
190
Differential Diagnosis
of infected carrier
Common pathophysiology: Degradation of the vascular system
Varicella, monkeypox, cowpox, erythema multiforme, contact
and coagulopathy
dermatitis
History/Physical Examination
Management
Fever, myalgias, weakness
Initial outbreak response focuses on containment of symptomatic
Microvascular degradation, coagulopathy, and complement
patients
system activation
--------------------------------------- 53
192
--------------------------------------- 54
liiif.
Ch. 25: Prevention of Infection
- Hypotonic-hyporesponsive episodes: varies from 3.5 to
Prevention
291 episodes per 100,000 doses
195
of Infection
- Prolonged crying for 3 hours or more after DTP vaccination: One episode per 100 doses
- Measles-mumps-rubella (MMR):
- Fever 39.4C or higher lasting 1 or 2 days in the 6 to 12
JeanO. Kim, MD
days following MMR vaccination in 5% to 15% of recipients
- Transient thrombocytopenia in 1 per 25,000 to 40,000
Active Immunization
MMR vaccine recipients
Stimulating humoral or cellular immunity by administering
- Varicella:
vaccine or toxoid
- Mild varicella-like illness (typically 15 to 30 vesicles) in
Immunologic response by host similar to that induced by natuI%to4%
ral infection but with fewer complications
- Fever 38.0C or higher in 10% of adolescent and adult
Protection may be lifelong or short term
varicella vaccine recipients
More information about the VAERS system can be found on
Usually administered before exposure to infectious agent, but
the web at www.vaers.org. A table of reportable/reported
may be given following exposure (see "Chemoprophylaxis")
adverse vaccine reactions can be found at http://www.vaers.
Types of Vaccines
org/reportable.htm. In addition, reports can be phoned in to 1Live attenuated: Weakened infectious agents that cause trivial
800-822-7967.
active infections (varicella, oral polio, and measles, mumps,
rubella vaccines)
Inactivated: Killed infectious agents that do not cause active
Passive Immunization
infections
Subunit preparations: Components (proteins or polysacchaAdministration of preformed protection (e.g., antibody) to an
rides) of infectious agents
infectious agent to a host.
NOTE: Polysaccharide antigens produce suboptimal antibody
Indicated in the following:
response in hosts younger than 2 years; protein conjugation
- Pre-exposure: The patient is unable to mount an antibody
response to an infectious agent due to congenital or acquired
improves antibody production significantly
immunodeficiency
Recommended childhood and adolescent vaccine schedule
- Postexposure: Exposure to an infectious agent placed
available at the Centers for Disease Control and Prevention
patient at high risk for complication from disease
--------------------------------------- 55
196
197
hepatitis 8 vaccine
recipients of one IVIG product. As IVIG is a human blood
product, it is screened for HIV, HBV, and, now, HCV.
Varicella-zoster immune Varicella exposure in susceptible hosts:
globulin (VZIG)
Administer IM,
history of VZV
Chemoprpphylaxis
May use IVIG if IM injection2) Pregnanst women without VZV antibodies
contraindicated
3) Newborn whose mother had VZV onset
Administering antibiotics to prevent infection
within 5 days before or 48 hours after delivery
Postexposure Prophylaxis
4) Hospitalized premature infant 28 weeks or
more gestation
Indicated to prevent infection by highly
history of VZV
pathogenic organisms (Table 25-3)
or weight 1000
maternal history
Cytomegalovirus immune
CMV-seronegative kidney or liver transplant
TABLE 25-3 Postexposure Prophylaxis Regimens
globulin (CMVIG)
recipients of CMV-positive organs
Respiratory syncytial virus immunPreventioen of RSV infection in children
Disease"
Management of Exposure
globulin (RSV IVIG) or RSVyounger than 2 years requiring medical
Meningoaxaif infection
Rifampin (2 days), ceftriaxone (1 dose), or dprofloxad
n
monoclonal antibody*
therapy for chronic lung disease or born
32 weeks or less gestation
fldose)
TB 1NH; add rrfampin if exposed to INH-resistantTB
"See "Infections Following Bites" (Chapter 16) for discussion of rabies immune g
lobulin.
individual
6 RSV monoclonal antibody does not interfere with administration of live virus v
accines; administer IM. Place tuberculin skin test initially and repeat at 3 mont
hs;
if positive, continue therapy for 9 months, if negative at
3
months discontinue therapy
TABLE 25-2 Therapeutic Indications for Immune
Pertussis Erythromycinestoiate(14days).Azithromycin (5-7 days)
may be as effective
Globulin Products
Hepatitis B infection
None if exposed person has positive HBsAb
Product
Therapeutic Indication(s)
HBIG once and begin HBV series if exposed person never
Intravenous immune
Replacement for IgG deficiency; Kawasaki disease;
vacdnated; HBIG twice if exposed person vaccinated but
globulin (IVIG)
3,and 6 months
Cytomegalovirus immunCMVIe G may be synergistic in managing CMV
Hepatitis C infection
No prophylaxis available.Evaluation:HCV Ab.liver
globulin (CMVIG)
pneumonia in bone marrow transplant patients
enzymes at baseline, 3, and 6 months
when given withganciclovir
Influenza Arnantadine,rimantadine,oroseltamivirfor5days
Botulinum immune globuliInfantilne botulism; use equine-derived antitoxin in
Also give influenza vaccine if unvaccinated
(HBIG; human botulinumhypersensitivity-tested adults if HB1G not available
Varicella*
antitoxin)
VaricellavaccineuptoSdaysafterexposure
--------------------------------------- 56
198
199
lnfect{on Control
Contact Clostrldim difficile colitis; draining abscess; enteroviruses; hepati
tis A,
herpes simplex virus {mucoortaneous); herpes zoster," lice (pedicul
osis);
Infection control programs are mandatory for all health care
multid rug-resistant bacteria,' parainfluenza, respiratory syncytial
virus,
organizations
rotavirus; scabies; shigellosis; viral hemorrhagic fever
Policies based on recommendations of national associations
Droplet Adenovirus;8refefe//opertass/5;ttiemopMjMi/enzaetypeb;
including the Centers for Disease Control and Prevention (CDC),
influenza; mumps; Mycoplasma pneumoniae; Neisseria meningitidei;
the Society for Healthcare Epidemiology in America (SHEA),
parvovirus B19;rubella;streptococcal pharyngitis
Airborne Measles;smallpox;tuberculosis;varicella-zoster virus
"Imnuifiocornpromised hosts with herpes zoster infection and immunocompetent
hosts with
TABLE 25-4 Disease Transmission and Precautions
disseminated disease may shed varicella virus from the respiratory tract a nd
requ ire contact pi us
airborne isolation for the duration of illness.
Mode of
'Methidllin-resistantSfap/iytococcas<iureus,vancomycin-resistantenterococd,gl
ycopeptide
Transmission
isolation Precaution
intermediate/resistant S.ffl/deifi,extended-spectnimp-tactamase-produdnggranr
Hiegative bacteria.
Standard Applicable to all body fluids Han,d hygiene (hand washing
secretions, and excretions excepor uset of alcohol-based
sweat. Consider all patients aproducts) between patients
and the Joint Commission on Accreditation of Healthcare
possibly infectious for bloodan-d after removal of other
Organizations (JCAHO).
borne pathogens, such as HIprotectivVe gear
Traditionally infection control programs focused on nosocoGloves to be worn when touching blood, body fluids,or conmial infections. However, basic principles now applied to settaminated items
tings outside of the hospital, including outpatient clinics,
long-term care facilities, and home health
Masks and/or eye protection if
generation of spray or splash of
General Principles of Isolation
fluids possible
Gowns (nonstertle) to prevent
oal is to limit transmission from infected host to other persons
; sailing of clothing and protect
--------------------------------------- 57
;lueprints Pediatric Infectious Diseases
Ch.1:Diagnostic Microbiology
3
TABLE 1-1 Correlations of Staining Result
ABLE 1-2 Examples of Direct Specimen
with Possible Organisms
Diagnostic Testing
Preliminary Staining ResultPossible Organisms
Infectious Agent Comments
Catalase-positive,gram-positiveStaphylococcus, Micrococcus, Aemcoccus
Bartone/la henselae IFA; sensitivity 95%, specificity 95%
cocci
Bordetellapertussis PCR (new gold standard), DFA
Catalase-negative, gram-positiveStreptococcus, Enterococcus, Abiotrophia,
Chlamydia trachomatis EIA for antigen; DFA, LCR, PCR; DNA probe
cocci
Leuconostoc, Pediococcus, Gemella,
Aemcoccus, Lactococcus, Globicatella
(lostridium difficile Toxin A and B detection
(lostridium botulinum Toxin detection (stool)
Nonbranching, catalase-positive,Bacillus, Listeria, Corynebacterium, Kurthia,
coli 0157 EIA for Shiga toxin; peak 2-3 weeks after initial infection
gram-positive bacilli
Juricella
Legionella pneumopbila DFA; Urine antigen test detects L pneumophila serogroup
1
Nonbranching, catalase-negative,Erysipelothrix, Lactobacillus, Arcanobacterium
,
gram-positive bacilli
Loctobacillus, Gardnerella
(sensitivity 80%)
Branching or partially acid-fastNocardia, Streptomyces, Rhodococcus,
Mycoplasma pneumoniae PCR
Neisseriagonorrhoeae LCR; DNA probe
gram-positive bacilli
Oerskovia, Tsukamurella, Gordona, Rothia
Gram-negative bacilli and Enterobacteriaceae,/4cmefo6flcfer,
Streptococcus pneumoniae Antigen testing (urine);tests positive in vaccinated
coccobacilli (Mac+, oxidase negative)Chryseomonas, Flavimonas, Stenotrophomonas
children
Gram-negative bacilli and Pseudomonas, Burkholderia, Ralstonia,
Streptococcuspyogenes Rapid Streptococcus antigen, DNA hybridization,
coccobacilli (Mac +, oxidase +)Achromobacter group, Ochrobactrum,
agglutination (ASO)
Cbryseobacterium, Akaligenes, Bordetella (excl.
B. pertussis), Comamonas, Vibrio, Aeromonas,
Plesiomonas, Chromobacterium
atmospheric requirements (aerobic, anaerobic, COJ; plus use
Gram-negative bacilli and Moraxello, elongated Neisseria, Eikenella
of spot tests: oxidase, catalase, indole, etc.
coccobacilli (Mac-,oxidase+)cormdens, Pasteurel/a, Actinobacillus, Kingella,
ommercial systems: Rapid (4 hour) or overnight; automated
Cardiobacterium,Capnocytophaga
Typ
D
NA sequencing: Generally used for other species (i.e., M.
morphology on culture media (hemolysis, non-lactose fermenter, etc.); microscopic staining characteristics (pairs, chains);
kansasii, M. gordonae)
--------------------------------------- 58
20
21
- Solution: No great solution. Sometimes an increase in antibiotic concentration alone is not enough to overcome this
alteration in antibiotic transport. Occasionally, a specific combination of drugs provides a synergistic antibacterial effect.
Other example, carbapenems penetrate OprD porins of many
gram-negative rods. Carbapenem-resistant Pseudomonas
aeruginosa mutants lack OprD
-1)
--------------------------------------- 59
Appendix A
201
Opportunities in
Career Opportunities in Pediatric
Pediatrics and Pediatric
Infectious Diseases
Infectious Diseases
According to the Pediatric Infectious Diseases Society, two thirds
of all board-certified pediatric ID physicians practice in a medical
school or university setting. They may see ID patients in the inpatient or outpatient setting, teach residents and medical students,
Pediatric Res{dency Training
conduct research, or perform a combination of these activities.
Other pediatric ID physicians work at public health agencies
There are currently 213 accredited categorical pediatric residenincluding the Centers for Disease Control and Prevention and the
cy training programs in the United States and 16 accredited proNational Institutes of Health. In this capacity, the investigate disgrams in Canada. Each year 2500 to 3000 residents begin pediease outbreaks, educate the public, and provide leadership in the
atric training. At the completion of a 3-year residency, candidates
field of infectious diseases epidemiology. ID specialists are also in
may take the General Pediatrics Certifying Examination to
great demand by pharmaceutical companies. Their expertise perbecome a board-certified pediatrician.
mits involvement in many aspects of the development of vaccines
and antimicrobial, antiviral, and antifungal agents. Approximately
Pediatric Subspecialty Training
5% of pediatric ID specialists are engaged in private sector patient
care. Some specialists practice exclusively in the office setting
Each year 25% to 30% of graduating pediatric residents begin
Infectious diseases
pediatrics
Neonatal-perinatal medicine
Cardiology
Nephrology
Critical care
Pharmacology-toxicology
Emergency medicine
Pulmonology
Endocrinology
Rheumatology
Gastroenterology
Sports medicine
--------------------------------------- 60
Appendix B
203
A. Gentamicin
Review Questions
B. Ciprofloxacin
C. Cephalexin (first-generation cephalosporin)
and Answers
D. Imipenem
E. Amoxicillin
5. A 9-year-old girl was diagnosed with pneumonia and treated with
amoxicillin. She remains febrile after 48 hours of therapy. In addiQUESTIONS
tion, she complains of pleuritic chest pain. What should be the next
step in the evaluation?
1. A 3-year-old girl presents with unilateral eyelid edema and eryA. Nasopharyngeal bacterial culture
thema with mild proptosis. Extraocular movements are restrictB. Transthoracic needle biopsy
ed. Orbital CT scan confirms the diagnosis of orbital cellulitis.
C. Mycoplasma polymerase chain reaction of the nasopharyngeal
aspirate
What is the most appropriate antibiotic for empiric therapy in this
patient?
D. Chest radiograph
A. Tetracycline
E. Radionuclide milk scan
6. Which of the following is associated with toxic shock syndrome due
B. Ceftazidime
C. Ampicillin-sulbactam
to Streptococcus pyogenesl
D. Trimethoprim-sulfamethoxazole
A. Epstein-Barr virus infection
E. Metronidazole
B. Tampon use
2. An 18-month-old boy awakens with a hoarse voice and a seal-like
C. Varicella infection
"barking" cough. He is relatively well appearing.The oxygen saturaD. Prolonged hospitalization
E. Stepping on a nail through a rubber-soled sneaker
tion is 100% in room air.On examination, he has suprasternal retractions and mild inspiratory stridor. What is the most appropriate
7. A 12-year-old boy presents to the emergency department with an
management?
infected hand wound. Eikenella corrodens is isolated from wound
culture. What is the most likely mechanism of injury?
A. Oral dexamethasone (0.6 mg/kg)
--------------------------------------- 61
204
D. Oseltamivir
E. Chicken soup
A. Direct inoculation from surgery
B. Direct inoculation from penetrating trauma
19. A 12-month-old girl presents for evaluation of fever and abdominal
C. Hematogenous seeding after bacteremia
pain. Urinalysis reveals 2+ leukocyte esterase by dipstick. What
D. Spread from adjacent septic arthritis
pathogen will most likely be isolated from urine culture?
E. Spread from adjacent cellulitis
A. Escherichia coli
14. Which of the following is considered a HACEK organism?
B. Staphylococcus aureus
C. Staphylococcus saprophyticus
A. Haemophilus influenzae type b
D. Corynebacterium species
B. Arcanobacterium haemolyticum
E. a-Hemolytic streptococci
C. Cytomegalovirus
D. Escherichia coli
20. Seizures are an extraintestinal manifestation of which of the followE. Kingella species
ing gastrointestinal pathogens?
--------------------------------------- 62
Blueprints Pediatric Infectious Diseases
Appendix B
207
A. Campylobacter jejuni
25. A 10-year-old boy presents to the emergency department several
B. EscherichiacoliO-\57:H7
hours after eating leftover fried rice at home. He complains of nauC. Yersinia enterocolitica
sea and diarrhea. You suspect food poisoning. What is the most likeD. Clostridium difficile
ly organism?
E. Shigella species
206
A. Bacillus cereus
21. A 4-year-old girl with acute lymphocytic leukemia has been neuB. Kingella kingae
tropenicfor21 days during induction chemotherapy. She now comC. Cryptosporidium ovale
plains of headache and facial pain. On examination, there is left periD. Enterobius vermicularis
orbital swelling. A small area of blackened eschar is noted within the
E. Clostridium difficile
nose. Sinusitis due to Aspergillus species is suspected. What is the
most appropriate therapy while awaiting surgical debridement?
A. Fluconazole
B. Voriconazole
C. Nystatin
D. Clotrimazole troches
E. Acyclovir
22. A 6-month-old girl presents with severe hypoxia and tachypnea. On
examination there are marked intercostal retractions but few rales.
In talking with the mother you discover that the father is HIV positive.The mother has never been tested.This information,combined
with the clinical presentation, makes you suspect Pneumocystis
carinii pneumonia. You order a bronchoscopy. Which of the following tests would be most useful in making the diagnosis?
A. Gomori silver stain
B. Ziehl-Neelsen stain
C. Kirby-Bauer test
D. India ink stain
E. Plate on chocolate agar
23. A 17-year-old boy with a ventriculoperitoneal shunt presents with
headache, fever, vomiting, and photophobia. Which of the following
organisms is most likely to cause a ventricular shunt infection?
A. Streptococcus pneumoniae
B. Citrobacter diversus
C. Group B Streptococcus
D. Streptococcus miller! group
E. Staphylococcus epidermidis
24. A 2-year-old child is evaluated in the infectious diseases clinic for
recurring "boils/'What is the medical term for "boil"?
A. Bordet-Gengou
B. Shell vial
C. Furuncle
D. Tache noir
E. Bubo
--------------------------------------- 63
208
209
8. A
9. D
--------------------------------------- 64
210
wool sorter's disease because it often occurred among workers hanunknown origin.
dling infected hides and wool. Dog bite infections can be caused by
Pasteurella species and Capnocytophaga species. Lawn mower
10. C. The rash is classic for the erythema migrans rash seen with
injuries can be complicated by infection with organisms from the
Lyme disease. Untreated, the rash may gradually expand to 15 to
skin or soil, including staphylococci, Escherichia coli, Aemmonas
30 cm in diameter; hence the name "migrans." The appropriate
hydrophila, Stenotrophomonas maltophilia, Pseudomonas species,
treatment for this early localized stage of Lyme disease is doxyEnterobacter species, and Clostridium tetani. In injuries or bites occurcycline. In younger children, amoxicillin can be used.Typical duraring in marine environments, consider Vibrio species, Aemmonas
tion of treatment is 14 to 21 days. When the rash has such a classic
hydrophila, Plesiomonas shigeltoides, and Pseudomonas species.
appearance, confirmatory antibody studies are not required.
8. A. This child has Kawasaki syndrome. Treatment with gamma
Furthermore, early in the course of Lyme disease, antibody studies
may be negative. The rash seen in Rocky Mountain spotted fever
globulin within 10 days of symptom onset reduces the incidence
begins on the extremities and migrates centrally.The rash is typicalof coronary aneurysms in Kawasaki syndrome from 15%-25% to
ly macular progressing to petechial. Blood culture and empiric cef5%. High-dose aspirin NOT acetaminophen is used in the management of Kawasaki. Amoxicillin is used to manage scarlet fever, an
triaxone would be reasonable if this were a petechial or purpuric
rash, raising concern for meningococcemia. An electrocardiogram
infection caused by group A Streptococcus. Scarlet fever is often
detects atrioventricular heart block, a complication of early dissemiincluded in the differential diagnosis of children with Kawasaki syndrome. However, while uveitis is seen in up to 80% of children with
nated (stage 2) Lyme disease. Since there is only a solitary lesion, this
--------------------------------------- 65
212
routine culture medium. Therefore, when endocarditis is suspectshould be started at approximately 6 weeks of life and can be dised, blood cultures should be retained for at least 2 weeks to allow
continued at 4 months if the HIV DNA PCR result remains negafor growth of a HACEK organism.These organisms are best treattive. The HIV ELISA is an IgG-based test. Infants born to HIV-positive
ed with a third-generation cephalosporin. H. influenzae type b
mothers have detectable HIV antibodies from intrapartum transmission.This reflects the HIV status of the mother not the infant. The
(HIB) was formerly a common cause of childhood meningitis. With
passively acquired antibodies may persist until 15 to 18 months of
the introduction of routine HIB, this organism rarely causes invasive
age in uninfected infants. The CD4+ count is normal in most H1Vinfection in immunized populations. A. haemolyticum causes
infected neonates.This test would not detect the majority of infectpharyngitis associated with a scarlatiniform rash on the extensor
ed neonates.The HIV Western blot test is used to confirm a positive
surfaces of the arms and legs. Cytomegalovirus is associated with
ELISA. Since this is also an IgG antibody-based test, this infant will
congenital infections and infectious mononucleosis; in addition, in
have detectable antibodies from passive maternal transfer during
immunocompromised patients, pneumonia. coll, a gram-negative
the third trimester. Antibodies detected in an infant this young
rod, causes many different types of infections including urinary tract
reflect the HIV status of the mother, not the infant The total WBC
infections, neonatal meningitis, and catheter-related bloodstream
count is usually normal in HIV-infected neonates. This would not
infections. It does not have fastidious growth requirements.
help distinguish infected from uninfected neonates.
15. A.The CSF findings in bacterial meningitis vary depending on the
12. E. DiGeorge syndrome is due to defective embryologic developinfecting organism as well as the timing of the lumbar puncture
ment of the third and fourth pharyngeal pouches. Affected chilin relation to onset of symptoms. Bacterial meningitis is usually
dren have variable deletions of chromosome 22q11.The thymus
associated with dramatic neutrophilic CSF pleocytosis. The prois usually hypoplastic or absent. Associated cardiac defects intein content is high due to leptomeningeal inflammation while
clude conotruncal defects, atriat and ventricular septal defects,
the glucose content is low (less than two thirds the serum level).
and aortic arch abnormalities. Other associated defects include
Tuberculous meningitis presents with a mild pleocytosis but a drapalatal insufficiency, esophageal atresia, and bifid uvula. Wiskottmatically elevated protein and low glucose.Children may have assoAldrich syndrome is associated with the triad of immunodeficiency,
ciated miliary disease. Viral meningitis (often enteroviruses in the
eczema, and thrombocytopenia. Transient hypogammaglobulinesummer) may have a neutrophil predominance early in the illness.
mia of infancy is an abnormal delay in the onset of antibody proAs the illness progresses, a lymphocyte predominance develops.
duction. It is not associated with cardiac defects. IgA deficiency is
The protein may be normal or mildly elevated but the glucose is
normal. Lyme meningitis typically presents with a prolonged period
the most common antibody deficiency with a prevalence of 1 in
of symptoms (often up to 2 weeks). Similar to enteroviruses, Lyme
400.ln most children infection is asymptomatic. Some children presmeningitis is most common during the summer months. The pleoent with recurrent sinopulmonary infections. Children with chronic
--------------------------------------- 66
214
21
23.
tricular shunt infections in older children. Bacteria of the Strepto20. E. Seizures may precede the bloody diarrhea in children with
Shigella infection, making the diagnosis difficult at first. Campylococcus miller! group are associated with intracranial complications
bacter infections are associated with reactive arthritis, erythema
of sinusitis.
nodosum, and Guillain-Barre syndrome. Escherichia coti 0157:H7 is
C. The word "boil" is the lay term for furuncle, a bacterial infection
associated with hemolytic uremic syndrome. Yersinia enterocolitica
of the hair follicle. Bordet-Gengou is the culture medium for growing
is associated with erythema nodosum, glomerulonephritis, and
Bordetella pertussis. The shell vial assay is performed by inoculating
24.
--------------------------------------- 67
216
va
Re
ference) to confirm dosing and view information on side effects,
develops acute onset of high fever, malaise, myalgias, headache,
ug interactions, and contraindications.
nausea, and vomiting. The bubo is accompanied by skin lesions in
dr
age >1 but <2 years) or 400 mg (if >2 years) as a single dose
than 6 hours (preformed toxin: Staphylococcus aureus, Bacillus
Am
oxicillin " Standard dose: 20-40 mg/kg/d divided TID;"High-dose": 80-90
cereus); 8 to 16 hours {Clostridium perfringens, B. cereus); 16 to 96
mg/kg/d divided TID; adults 250-500 mg TID (max. 3 g/d);
hours (Shigella, Salmonella, Vibrio spp., invasive Escherichia coli.
endocarditis prophylaxis 50 mg/kg (max. 2 g) 1 h before proceCampylobacterjejuni, Yersinia enterocolitka, caliciviruses). Kingella
dure
kingae is associated with arthritis and endocarditis. Cryptosporldium
Am
oxicillm-clavulanate" Dosing based on amoxicillin component.To avoid excessive
ovale causes diarrhea in immunocompromised patients, especially
adverse Gl events, use amoxicillin 600 mg/clavulanic potassium
those with HIV infection. Enteroblus vermkularis is also known as
42.9 mg per 5 mL formulation (ES-600) if the dose of clavulanic
pinworm. It usually causes perineal pruritis and occasionally causes
acid exceeds 10 mg/kg/d using the regular-strength formulaabdominal pain. It can be detected by placing cellophane tape
tion
("Scotch tape" test) around the perineum and then examining the
Az
ithromycin" Most infections: 10 mg/kg (max. 500 mg) on day 1, then
tape under the microscope. It does not typically cause diarrhea.
5 mg/kg/d QD (max. 250 mg) days 2-5; uncomplicated
Clostridium difficile usually causes diarrhea or colitis in association
chlamydial cervicitis: 10 mg/kg as single dose (max. 1 g)
with broad-spectrum antibiotic use.
ftibuten" 9 mg/kg/d once each day; adults 400 mg QD (max. 400 mg/d)
Ce
Ce
--------------------------------------- 68
218
Levofloxacin"
Suggested Additional
Mebendazole
Pinworm: 100 mg initially and repeated 2 weeks later D
Metronidazole'
Giardia: 15 mg/kg/d divided TID; (lostridium difficile infecti
ons
Reading
20 mg/kg/d divided QID; adults 250-500 mg Ql D
Nitazoxanide'
Paromomycin
CHAPTER 3
Penicillin V potassium15-50 mg/kg/d divided TID or QID; children >12 years and
adults 125-500 mg TID or QID (max.3 g/d)
H
enry NK, Hoecker JL, Rhodes KH. Antimicrobial therapy for
Rifampin
Meningococcal prophylaxis: 20 mg/kg/d divided BID x 2 days;
adults 600 mg BID x 2 days (max. 1200 mg/d)
infants and children: guidelines for the inpatient and outpatient practice of pediatric infectious diseases. Mayo Clin Proc
Tetracycline"
20-40 mg/kg/d divided QID; adults 250-500 mg BID to QID
2000;75:86-97.
(max. 2 g/d)
L
eclercq R. Mechanisms of resistance to macrolides and linTrimethoprimMild-moderate infections: 6-12 mg TMP/kg/d divided BID; seriou
s cosamides: nature of the resistance elements and their clinical
sulfamethoxazole" infections:20 mg TMP/kg/d divided BID; adults 1 double-strengt
h implications. Clin Infect Dis 2002;34:482-492.
(dosing based on tablet (160 mg TMP) BID (max. 320 mg TMP/d)
trimethoprim component)
ong SS, Dowell SF. Principles of anti-infective therapy. In: Long
--------------------------------------- 69
Chapt
er
22
cy
Theoklis E.Zaoutis, MD
+ + + + +
11+ i
1 1 1
it i
of amphotericin B (amphotericin B lipid complex, amphotericin B cholesteryl sulfate, liposomal amphotericin B)
ro .S
Azoles
i i "i + i + +
; >= s
' Mechanism of action: Inhibits cytochrome P-450 enzymes
^f
used in the synthesis of the fungal cell membrane
S
Mechanism of resistance: Resistance to azoles can develop by
III+ + + + l +
cS
several different mechanisms, including decreased membrane
permeability, altered membrane sterols, active efflux, altered or
overproduced target enzyme, and compensatory mutations in
if
jj E
the desaturase enzyme. The category of DBS (dose dependent
susceptible) has been created for azoles to characterize isolates
with intermediate resistance that can be inhibited by higher
doses of drug. DOS isolates may be treated successfully with
12 mg/kg/d of fluconazole
23
--------------------------------------- 70
220
--------------------------------------- 71
Blueprints Pediatric Infectious Diseases
Appendix D
223
American Academy of Pediatrics. Practice parameter: the diagnosis,
Klein JO. Management of the febrile child without a focus of
treatment, and evaluation of the initial urinary tract infection in
infection in the era of universal pneumococcal immunization.
febrile infants and young children. Pediatrics 1999;103:843-852.
Pediatr Infect Dis J 2002;21:584-588.
Hoberman A, Wald ER, Hickey RW, et al. Oral versus initial intraMermel LA, Farr BM, Sherertz RJ, Raad II, O'Grady N, Harris JS.
venous therapy for urinary tract infections in young febrile chilGuidelines for the management of intravascular catheter-related
dren. Pediatrics 1999;104:79-86.
infections. Clin Infect Dis 2001;32:1249-1272.
Lohr JA, O'Hara SM. Renal (intrarenal and perinephric) abscess.
222
In: Long SS, Pickering LK, Prober CG, eds. Principles and practice of pediatric infectious diseases, 2nd edition. New York:
CHAPTER 16
Churchill Livingstone: 2003:329-333.
Seigel RM, Schubert CJ, Meyers PA, Shapiro RA. Prevalence of
Appelgren P, Bjornhagen V, Bragderyd K, Jonsson CE, Ransjo U.
sexually transmitted diseases in children and adolescents evaluA prospective study of infections in burn patients. Burns
ated for sexual abuse in Cincinnati: rationale for limited STD
2002;28:39-46.
testing in prepubertal girls. Pediatrics 1995;96:1090-1094.
Bell LM, Baker MD, Beatty D, Taylor L. Infections in severely
traumatized children. J Pediatr Surg. 1992;27:1394-1398.
Pediatr 2003;15:92-96.
Occult bacteremia from a pediatric emergency department:
--------------------------------------- 72
224
111:1475-1489.
2000;12:269-274.
Working Group on Antiretroviral Therapy and Medical ManageMandl KD, Stack AM, Fleisher GR. Incidence of bacteremia in
ment of HIV-Infected Children. Guidelines for the use of antiinfants and children with fever and petechiae. J Pediatr 1997;
retroviral agents in pediatric HIV infection. Updated and avail131:398-404.
able on line: http://aidsinfo.nih.gov/ (revised June 25, 2003).
Maslers EJ, Olson GS, Weiner SJ, Paddock CD. Rocky Mountain
spotted fever: a clinician's dilemma. Arch Intern Med
2003;163:769-774.
Nelson B, Jill S, Stone MS. Update on selected viral exanthems.
CHAPTER 23
Curr Opin Pediatr 2000;12:359-364.
Burnett MW, Bass JW, Cook BA. Etiology of osteomyelitis comRosenstein NE, Perkins BA, Stephens DS, Popovic T, Huges JM.
plicating sickle cell disease. Pediatrics 1998;101:296-297.
Meningococcal disease. N Engl J Med 2001;344:1378-1388..
Davis PB, Drumm M, Konstan MW. Cystic fibrosis. State of the
Steele AC. Medical progress: Lyme disease. N Engl J Med
art. Am J Respir Crit Care Med 1996;154;1229-1256.
2001;345:115-125.
Fishman JA, Rubin RH. Infection in organ-transplant recipients.
Wells LC, Smith JC, Weston V, Collier J, Rutter N. The child with
a non-blanching rash: how likely is meningococcal disease?
N Engl] Med 1998;338:1741-1751.
Arch Dis Child 2001;85:218-222.
Green M, Michaels MG. Infections in solid organ transplant
recipients. In: Long SS, Pickering LK, Prober CG, eds. Principles
and practice of pediatric infectious diseases, 2nd ed. New York:
CHAPTER 20
Churchill Livingstone, 2003:554-561.
Ho M, Miller G, Atchison W, et al. Epstein-Barr virus infections
Hughes WT, Armstrong D, Bodey GP, et al. 2002 Guidelines for
and DNA hybridization studies in post transplantation lymthe use of antimicrobial agents in neutropenic patients with
phoma and lymphoproliferative lesions: the role of primary
cancer. Clin Infect Dis 2002;34:730-51.
infection. J Infect Dis 1985;152:876-886.
--------------------------------------- 73
226
Norris CF, Smith-Whitley K, McGowan KL. Positive blood cultures in sickle cell disease: time to positivity and clinical out-
epidural, 43-44
modified, 7
Henretig FM, Cieslak TJ, Eitzen EM. Biological and chemical terhepatic, with cancer, 160t
rorism. J Pediatr 2Q02;141:311-326.
peritonsillar and
Agammaglobulinemia, X-linked
Patt HA, Feigin RD. Diagnosis and management of suspected
retropharyngeal, 49-52
(Bruton), 173-174
cases of bioterrorism: a pediatric perspective. Pediatrics 2002;
AIDS. See Human
renal, 93-94
immunodeficiency virus
109:685-692.
Absidia, 6
[HIV) infection
Swartz MN. Recognition and management of anthrax: an update.
Absolute lymphocyte count
NEnglJMed2Q01;345:l62l-1626.
(ALC), in severe combined
Airborne precautions, 198*, 199f
Albendazole, 217
immunodeficiency, 175
Absolute neutrophil count
CHAPTER 25
(ANC), 154, 156
Aminoglycosides, spectrum of
resistance to, 29
for sinusitis, 59
Adenoviridae, 12t
Adenovirus
Amoxicillin-clavulanate, 217
Amphotericin B, spectrum of
--------------------------------------- 74
228
Index
Index
229
Ampicillin, spectrum of activityAntimicrobial susceptibility
laboratory methods to
Bloodstream infections, 111 118
of, 2U
testing, 4
identify, 1-3, 2t, 3t
central venous catheterAmpicillin-sulbactam, spectrum Antiretroviral agents, for HIV
microscopy (direct
related, 114-116, 114b, 116t
of activity of, 211
infection, 165-166, 166fo
examination) of, 1, 2t
sepsis, 111-113, 112fo
Amplification, of viruses, 14t, 16Antiviral agents, 27-29, 28t
susceptibility testing for, 4 toxic shock syndrome, 116-118
Azoles, 23-24
Burns, infections due to, 122-124
Antibody detection
botulinum, 192-193
for fungi, 8
plague, 187-189
for HIV infection, 163
smallpox, 190-191
for parasites, 11
tularemia, 189-190
--------------------------------------- 75
230
Index
Candida spp, 5
Chocolate agar, 1
antifungal agents for, 251
Cholangitis, 88-89
identification of, 8
Index
231
necrotizing fasciitis due to,
Conj uncti vitis
102-104
in neonate, 30-32, 3It, 32t
orbital and periorbital, 35-37
in older child, 32-33
Cervicitis, 94-96
antigen test for, 8
Cestodes, 9
Cryptosporidium parvum,
transmembrane conductance
CSF (cerebrospinal fluid)
regulator), 183, 184
evaluation
for encephalitis, 42
Charcot triad, in cholangitis, 89
for meningitis, 39, 40(
Chediak-Higashi syndrome, 176t
--------------------------------------- 76
232
Index
Index
233
disorders, 176
Erythema migrans (EM), 149,
183-185
Dimorphic fungi, 5
EM (erythema migrans), 149,
150
150
Cystic fibrosis transmembrane
conductance regulator
EMB (eosin-methylene blue)
agar, 1
(CFTR), 183, 184
Cystitis, 90-92, 91 b, 92f
Empyema, 67, 68t
subdural, 43-44
Cystourethrogram, voiding, 92t
with, 194-195
Encephalitis, 41-43
Escherichia coli
Cytology, of viruses, \5t, 16 Direct examination
antibiotics for, 21t-22t
Cytomegalovirus (CMV)
Encephalopathy, progressive,
of bacteria, 1, 2f
with HIV infection, 167
gastroenteritis due to, 811
antiviral agents for, 28f
of fungi, 7
meningitis due to, 411
congenital, 130-132
of parasites, 10-11
Endemic mycoses, 6
fever and rash due to, 152t
identification methods
Esophagitis
Direct specimen diagnostic
for, 8
with cancer, 160t
in organ transplant recipient, testing, 2, 3f
Candida, with HIV infection,
181
Endocarditis, 72-74, 73k
Disc diffusion test, 4
subacute bacterial, blood
168
Cytomegalovirus (CMV] endESP System, 5
organ disease, with HIV
DNA assay, for HIV infection,
cultures for, 5
infection, 167-168
164
Endomyocardial biopsy, 78
E test, 4
Cytomegalovirus immune
DNA sequencing, for
Endophthalmitis, 33-35
Exanthems, major childhood,
181-182
Exophiala wemeckii, 6
Dose dependent susceptible
Exudate, pleural effusion as, 67,
susceptible) azoles, 23
antibiotics for, 21t-22t
Deer fly fever, 189-190
(DOS) azoles, 23
central venous catheter-related68(
Doxycycline, 217
infection due to, 116t
Dehydration, due to
gastroenteritis, 80
Enterovirus
Echocardiography
with cancer, 154-156
deer fly, 189-190
of endocarditis, 74
Diarrhea
Electrocardiogram (ECG)
antiviral agents for, 281
in Kawasaki syndrome,
fever and rash due to, 152t,
with cancer, 160*
of myocarditis, 78
153
143-145
due to gastroenteritis, 79
of pericarditis, 76
--------------------------------------- 77
234
Index
Index
235
Fever (continued)
Fmncisella tularensis, 189
Gentamicin, for ophthalmia
Helminths, 9-10
in neonate, 135-136
Fungal endophthalmitis, 34, 35
neonatorum, 32t
Hepadnaviridae, 12r
and petechiae, 146-147, 147f
Q, 142t, 147
Fungi, 5-8
Gianotti-Crosti syndrome, 152f Hepatic abscess, with cancer, 160t
classification of, 5-7
Giardia lamblia, 82t
Hepatitis, 84-86, 85k, 86t
rabbit, 189-190
cutaneous/superficial, 5-6
Giemsa stain, 7
with cancer, 160f
and rash, 146-153
endemic/systemic, 6
due to Lyme disease,
laboratory methods to
GI infections. See
Hepatitis A, 86t
149-151
Gastrointestinal (GI) tract
fever due to, 142t
due to major childhood
identify, 7-8
infections
Hepatitis B immune globulin
opportunistic, 6-7
exanthems, 151-153,
structure of, 23
Gomori methenamine silver
(HBIG), 196f
152*
subcutaneous, 6
(CMS) stain, 7
Hepatitis B virus (HBV), 84, 86t
due to rickettsial infections,
147-149
Gradient diffusion test, 4
197f
Fever of unknown origin (FUO),
infection, 166k
Granulomatous disease, chronic,
137-139, 139t
176t
Hepatitis D, 86f
Griseofulvin, 24
Fever syndromes, periodic,
139-141, 140t
Group A Streptococcus (GAS)
Hepatitis E, 86t
Ganciclovir, spectrum of activity
fever due to, 142t
of, 28f
--------------------------------------- 78
236
Index
Index
237
HIV infection. See Human
IG. See Immune globulin (IG)
Immunoassay, for viruses, 14t IVIG. See Intravenous immune
immunodeficiency virus
IgA deficiency, 174
Immunocompromised hosts,
globulin (IVIG)
(HIV) infection
Immune deficiencies, inherited
infections in, 178-185
Hookworm, intestinal infection
(primary), 170-177
with cystic fibrosis, 183-185 Joint aspiration, for septic
with, 82t
cellular (T cell), 17It, 173,
with sickle cell disease,
arthritis, 106, 107
178-180, 179f
HSV. See Herpes simplex virus
solid organ transplant
(HSVJ
174-175
Joint infections, 105-107, 106t
combined (T cell and B cell),
Laryngotracheitis, 52-53
adverse events with,
Laryngotracheobronchitis, 52-53
195-197
for bronchiolitis, 63-64
Latex agglutination tests, 3
indications for, 196t
Leptospirosis, fever due to, 142f
for Kawasaki syndrome,
Leukocyte adhesion deficiency,
144-145
176t
respiratory syncytial virus,
Levamisole, for Ascaris
63-64, 196t
rabies, 122
lumbricoides, 82t
Levofloxacin, 218
tetanus, 196t
--------------------------------------- 79
238
Index
index
239
Lower respiratory tract
me/genes, mutation in, 20
spectrum of antifungal activityNebulized epinephrine, for
infections, 62-71
Meningitis, 38-41, 39r-41r
against, 26r
croup, 53
acute pneumonia, 64 67, 651,
cryptococcal, 40t
Molecular amplification, of
Necator americanus, intestinal
66r
enteroviral, 38, 40t
viruses, 14t, 16
infection with, 82r
bronchiolitis, 62-64
parameningeal, 38, 40t
"Monospot" test, for pharyngitis,Necrotizing fasciitis, 102-104
pleural effusion, 67-69, 6Sb, 68ftuberculous, 39, 40f
pulmonary lymphadenopathy,
49
197r
Neisseria gonorrhoeae
MRSA (methicillin-resistant
arthritis due to, 105, 106, 107
Lyme disease, fever and rash dueMetabolite tests
Staphylococcus aureus)
ophthalmia neonatorum due
to, 149-151
for fungi, 8
Lymphadenitis, cervical, 59-61
antibiotics for, 2lt-22t
for parasites, 11
to, 30, 31, Sir, 32r
146
osteomyelitis due to, 109t
osteomyelitis due to, 109r
pulmonary lymphadenopathy,
Mucocutaneous lymph node
meningitis due to, 41 r
71
Methicillin-sensitive
syndrome, 143-145
Nematodes, 9
Lymphocyte count, absolute, in
Staphyhcoccus aureus (MSSA),
osteomyelitis due to, 109r
Mucor, 6
Nephrectomy, for urinary tract
severe combined
Mucorales, antifungal agents for, infection, 94
immunodeficiency, 175
Metronidazole, 218
Lymphocytic interstitial
for Blastocystis hominis, S2t
26f
Neutropenia
pneumonitis (LIP), 167
for Giardia lamblia, 82t
Mulberry molars, in congenital
with cancer, 154-156
spectrum of activity of, 22t
syphilis, 128
cyclic, 176t
Lymphoma, HIV-related, 168
Neutrophil chemotaxis assay,
MIC (minimal inhibitory
Multiwell plate, for viruses, 14t 177
concentration), 4
Mycobacteria
MacConkey agar, 1
Neutrophil count, absolute, 154,
Macrolide(s)
Microbiology, diagnostic, 1-11
central venous catheter-related156
for bacteria, 1-5, 2t, 3t
infection due to, 116t
resistance to, 20
for fungi, 5-8
cervical lymphadenitis due to,Neutrophil disorders, 175-177,
spectrum of activity of, 211
for parasites, 8-11, 9t
60,61
176r
Macrophage disorders, 177
identification methods for, 3 Neutrophil expression of
Microscopy
Malaria, fever due to, 142r
of bacteria, 1, It
Mycobacterium avium,
CDllb/18, 177
Malassezia furfur, 6, 7
of fungi, 7
disseminated, with HIV
Niclosamide, for Taenia saginata,
antifungal agents for, 26r
of parasites, 10-11
infection, 168
82t
Mastoiditis, 56-57
Microsporidia, 9t
Mycobacterium tuberculosis
Nitazoxanide, 218
MBC (minimal bactericidal
Microsporum spp, 6
cervical lymphadenitis due to, for Cryptosporidium parvum,
60,61
concentration), 4
pneumonia due to, 66
Measles, 152, 152f
82r
Minimal bactericidal
Mycoplasma pneumoniae,
Measles-mumps-rubella (MMR)
concentration (MBC), 4
Nitroblue tetrazolium (NET)
176
(MIC), 4
MMR (measles-mumps-rubella)
Nontuberculous mycobacteria
--------------------------------------- 80
24
25
--------------------------------------- 81
240
Index
Index
241
Nucleic acid synthesis, inhibitorsParacoccidioides brasiliensis, 6
Perinatal infections. See
Pneumocystis carinii, 167
of, 19
Parainfluenza, antiviral agents for,
Congenital/perinatal infectionswith sickle cell disease, 179t
28f
Pharyngitis, 48-49
Osteochondritis, Pseudomonas,
(PID), 94-96
Phenotypic assays, for viruses, 15fPrevention, of infection,
109, 109t
Pelvic osteomyelitis, 108
Picornaviridae, 13f
194-199
by active immunization,
Osteomyelitis, 8k, 9t, 107-110 Penciclovir, spectrum of activity
PID (pelvic inflammatory
194-195
with sickle cell disease, 179t of, 28f
disease), 94-96
by chemoprophylaxis,
Otitis media (OM), 53-55
Penicillin, spectrum of activity of,
Piperacillin (PIPTAZ05),
197-198, 197t
Zlt
Ova and parasites (O&P)
spectrum of activity of, 22f by infection control, 198-199,
examination, 10
Penicillin-binding proteins
Pityriasis rosea, 152t
198t, 199t
(PBPs), 19
by passive immunization,
Oxacillin, spectrum of activity of,
Plague, 187-189
21t
Penicillin resistance, 19-20
Pleconaril, spectrum of activity
195-197, 196f
Oxazolidinone, spectrum of
Penicillin V potassium, 218
of, 28t
Prevnar (pneumococcal vaccine),
64
activity of, 22t
Penitillium marneffei, 6
Pleural effusion, 67-69, 68k, 68t
PEP (postexposure prophylaxis),
Pleural fluid assessment, 68, 68tProgressive encephalopathy (PE),
197-198, 197t
with HIV infection, 167
Palivizumab, for bronchiolitis, 64for HIV, 168-169, 169t
Pneumococcal vaccine (Prevnar), Prophylaxis
Papovaviridae, 12t
64
Papular acrodermatitis, 152t Percutaneous aspiration, for
Pneumocystis carinii pneumonia, chemo-, 197-198, 197t
urinary tract infection, 94
postexposure, 197-198,
Papular purpuric gloves and socks
167
197f
syndrome, 152f
Perianal cellulitis, with cancer, 160(
Pneumonia
for HIV, 168-169, 169t
Pericardiocentesis, 76
acute, 64-67, 65t, 66f
Paracentesis, for peritonitis, 87
for sickle cell disease, 180
Pericarditis, 74-77, 75k
with cancer, 158
for trauma, 120, 120t
--------------------------------------- 82
242
Index
Index
243
bronchiolitis, 62-64
Serology, of viruses, 15t
pleural effusion, 67-69,
Serum cidal test, 4
68k, 68t
Roundworms, 9
Rabies immune globulin (RIG),
pulmonary
intestinal infection with, 82tSevere combined
122
lymphadenopathy,
RSV. See Respiratory syncytial
immunodeficiency (SCID),
Racemic epinephrine, for
69-71, 70fc
virus (RSV)
174-175
bronchiolitis, 63
upper, 48-61
RTI (reverse transcriptase
Sexually abused child, infectious
Rash
cervical lymphadenitis,
inhibitors), for HIV infection,diseases in, 96-97
with cancer, 156
59-61
Sexually transmitted diseases
fever and, 146-153
croup, 52-53
Rubella, 152, 152(
(STDs), 96-97
due to Lyme disease,
mastoiditis, 56-57
congenital, 129-130
Shah, Suresh and Meena, 5/19
149-151
otitis media, 53-55
due to major childhood
peritonsillar and
Shell vial, for viruses, 14t
--------------------------------------- 83
244
Index
Index
245
Sickle cell disease, infections central venous catheter-related
Subdural empyema, 43-44
Tetracyclines, 218
with, 178-180, 179t
infection due to, 116t
64
Solid organ transplant recipients, scarlet fever due to, 152t
Toxic shock syndrome (TSS),
infections in, 180-183, ISlfc group B
Taenia saginata, intestinal
116-118
SPACE, antibiotics for, 21t-22(
antibiotics for, 21t-22(
infection with, 82t
meningitis due to, 411
Tapeworms, 9
Toxoplasma gondii, 126
Specific granule deficiency, 176t
--------------------------------------- 84
246
Index
Index
247
Trematodes, 10
Unilateral laterothoracic
Ventricular shunt infections, VZV (varicella zoster virus)
exanthem of childhood, 152t
46-47
antiviral agents for, 28t
Treponema pallidum, 127, 128
Trichinella spiralis, intestinalUpper respiratory tract infections
Vertebral osteomyelitis,
with cancer, 157
infection with, 82f
(URIs), 48-61
109
cervical lymphadenitis, 59-61
Vesicoureteral reflux (VUR), andWater-borne illness,
Trichophyton spp, 6
Trifluorothymidine, for
croup, 52-53
pyelonephritis, 90
gastroenteritis due to, 80
ophthalmia neonatorum, 32t
mastoiditis, 56-57
Vibrio choleras, gastroenteritisWestern blot, for HIV infection,
otitis media, 53-55
due to, 811
164
Trimethoprim-sulfamethoxazole
peritonsillar and
(TMP-SMX, Bactrim), 218
retropharyngeal abscess,
Vidarabine, for ophthalmia
Wiskott-Aldrich syndrome, 175
for Isospom belli, 82t
49-52
neonatorum, 32t
Worms, 9-10
for Pneumocystis carinii
pharyngitis, 48-49
Viral conjunctivitis, 32-33
Wound infections
pneumonia, 167
sinusitis, 57-59
Viral encephalitis, 42
due to bites, 121-122
spectrum of activity of, 22t
due to burns, 122-124
Urinary tract infection (UTI),
Viral hemorrhagic fever (VHF),
Trophozoite, 8
90-92, 91fc, 92f
142t, 191-192
due to trauma, 119-120, 119t,
Trypanosomiasis, fever due to, Urine culture, 91, 92t
Viral load (VL), for HIV
120t
142t
infection, 165
TSS (toxic shock syndrome),
Vaccine(s), 194-195
Virology, diagnostic, 12-17, Xigris (drotrecogin alfa), for
116-118
botulinum, 193
12t-15t
sepsis, 113
Tsutsugamushi, 147
pneumococcal, 64
Virus(es)
X-linked agammaglobulinemia,
Tuberculin skin testing (PPD), forwith sickle cell disease, 180
choosing tests for detection of,173-174
pulmonary lymphadenopathy,
smallpox, 191
15-16
71
Vaccine Adverse Event Reporting
classification and properties of,Yale School of Medicine, 1998
12, 12t, 13t
Tuberculosis (TB)
Typhus, 147
VCUG (voiding
cystourethrogram), 92f
Ultrasound, for urinary tract Velocardiofacial syndrome, 175
infection, 92
--------------------------------------- 85
THE In A Paqe
ALL the information for clinicals
and rotations - In A Paqe
Vital information on diseases
you will encounter
High yield and concise
Pediatrics
Saves time and helps you
remember - In A Paqe
Signs &
Symptoms
--------------------------------------- 86
26
Dimorphic Fungi
Mycosis
Drug of Choice
Alternative
Antiviral Agents
Histoplasma capsulatum Amphotericin B, itraconazoleFluconazole
Cocddioides immitis
Amphoteridn B, itraconazole,
Susan Coffin, MD,MPH
fluconazole, ketoconazole
Blastomyces dermatitidisAmphotericin B, itraconazoleFluconazole,
ketoconazole
Mechanisms of Action of Antiviral Agents
Spomthrixschenckii
Amphotericin B, itraconazoleFluconazole
Fluconazole Itraconazole
Ribavirin
Nucleoside analogues
Valacyclovir
" Caspofungin indicated for invasive aspergiliosis in patients whose infection
is refractory to, or who
are intolerant of, other therapies. For dosing guidelines, check with infectiou
s diseases specialists.Inhibition of Viral Protein Translation and Virion Assemb
ly
' Resistant to 5-FC, ketoconazole, fluconazole, echinocandins, miconazole, and
itraconazole.* Interferons
Protease inhibitors
Mechanisms of Resistance to Antiviral Agents
Our understanding of the incidence and mechanisms of antiviral
resistance remains incomplete. To date, three main mechanisms
of resistance have been identified:
1. Alteration of target site
2. Blocking of drug-induced changes in virus metabolism
3. Inhibition of drug activation
Example 1: HIV-1 develops resistance to nucleoside reverse
transcriptase inhibitors by modifying the HIV-1 pol gene, which
encodes viral reverse transcriptase
- Solution: Combination antiviral therapy will reduce the
--------------------------------------- 87
sprints Pediatric Infectious Diseases
Ch. 5: Antiviral Agents
29
- Si
pa
ti
ble; however, resistant subpopulations of influenza virus may
be
recovered within 48 hours of treatment with amantidine.
Th
e clinical significance of antiviral resistance among influenza
vi
ruses remains unclear, although failure of prophylaxis has
be
en reported during several nursing home outbreaks of infl
uenza
Exampl
e 3: Mutations in viral thymidine kinase induce herpes
simp
lex virus resistance to acyclovir by inhibiting drug phosphor
ylation
- So
lution: Subtherapeutic concentrations of acyclovir promote
th
e emergence of TK-deficient viruses. Therefore, the use of
+ 1 I + I I +
propriate drug dosages may reduce the risk of viral resistance
ap
Spectr
respon
(Table
5-1)
I I I I + + I I i I
I
I I I i I +
+ + I + I i I
I I + I I I I
! + !++[ I
I I I 1
f
rS
"s
'&
If
It
S
. .!= o tu 'g =5 '
i n ?
--------------------------------------- 88
Chapter
Ch.6:Ophthalmologic Infections
Ophthalmologic
TABLE 6-1 Testing to Detect Specific Causes
of Ophthalmia Neonatorum
Infections
Etiologic Agent Studies
31
Comments
Chemical
Gram stain
Many neutrophils; must evaluate
Leila M. Khazaeni, MD, and Monte D. Mills, MD
for other causes
Neisseria
gonorrhoeas
Ophthalmia Neonatorum
Chlamydia
Giemsa stain
or chocolate agar
Intracytoplasmic inclusion in
trachomatis1'
conjunctival epithelial cells
Conjunctivitis occurring during the first month of life
Direct fluorescentFluorescein-conjugated antibodies
antibody"
Epidemiology
B Risk Factors
Also available: direct fluorescent
antibody and polymerase
Inadequate prenatal screening of the mother for genital infecchain reaction
tions, failure to receive neonatal ocular prophylaxis
Pseudomonas aeruginosa affects hospitalized premature infants
Bacteria
Gram stain/culture"Gram stain suggestive; culture
confirms etiologicfactor(s)
as Etiology
" Preferred test.
Chlamydia trachomatis (8.2/1000 live births) most common in
' Specimen must contain conjunctival cells, not exudate alone.
industrialized nations
Etiologic agents and age of onset: Silver nitrate chemical conjunctivitis (1 day); Neisseria gonorrhoeae (3 to 5 days); C. trachomatis
Additional Studies (Table 6-1)
(5 to 14 days); herpes simplex virus (HSV) (5 to 30 days); bacteria (5 to 14 days; Staphylococcus aureus, Streptococcus pneumoii Differential Diagnosis
niae, viridans group streptococci, Haemophilus influenzae,
Birth trauma, corneal abrasion, foreign body, nasolacrimal duct
Escherichia coli, P. aeruginosa]
obstruction, dacryocystitis, congenital glaucoma
it Pathogenesis
Management (Table 6-2)
Three mechanisms of infection
In cases of chlamydial or gonococcal conjunctivitis, the mother
- Retrograde spread of organisms to fetal conjunctiva/cornea
after premature membrane rupture
and her sexual partner require evaluation and treatment for
sexually transmitted diseases
- Direct contact with infected genital secretions during vaginal delivery
Complications
- Direct contact with infected caregivers after birth
Chemical: None
' History/Physical Examination
N. gonorrhoeae: Corneal ulceration or perforation, endophthalmitis, arthritis, sepsis, meningitis
Red eye, purulent discharge
C. trachomatis: Corneal scarring, otitis media, pneumonia.
Conjunctival erythema, chemosis, lid edema
Vesicular eyelid rash with herpes simplex virus (HSV)
Pneumonia presents at 4 to 12 weeks of life. Findings include
staccato cough, tachypnea, and rales without fever
30
--------------------------------------- 89
32
33
II Differential Diagnosis
P. aeruginosa: Corneal ulceration or perforation; sepsis or
epharoconjunctivitis, allergic conjunctivitis, foreign body,
meningitis in 40% of premature infants with P. aeruginosa contrauma, chemical irritation, drug reaction, nasolacrimal duct
Bl
Ma
Complications
Usually bacterial, only 20% of cases are viral
y eyes, Subconjunctival scarring, keratitis, and entropion
Common causes:
- Bacterial: H. influenzas, S. fmeumoniae, N. gonorrhoeae, Moraxella
catarrhalis, S. aureus, Haemophilus aegyptius
Endqphthalmitjs
- Viral: Adenovirus, HSV, influenza, measles, varicella, EpsteinBarr virus
Infection of intraocular structures
--------------------------------------- 90
Dr
34
Or
Endogenous endophthalmitis: Hematogenous spread from disriorbital (preseptal) cellulitis: Infection of the skin and soft
tant infection
tissues anterior to the orbital septum
Orbital cellulitis: Infection of the tissues posterior to the
ii History/Physical Examination
orbital septum
Eye pain and redness, blurred vision, strabismus, recent trauma
Pe
S!
Epidemiology/Risk Factors
or surgery
Periorbital cellulitis: Trauma, skin infection, chalazion, dacryReduced visual acuity, conjunctival injection, chemosis, vitritis,
ocystitis, upper respiratory infection
retinal periphlebitis, uveitis, hypopyon, leukocoria
Orbital cellulitis: Chronic sinusitis, trauma, systemic infection
if Additional Studies
il Etiology
Obtain aqueous and vitreous specimens by aspiration with an
riorbital cellulitis: S. aureus, S. pneumoniae, H. influenzae
automated suction catheter
' Orbital cellulitis: S. aureus, S. pneumoniae, Streptococcus pyoSend for bacterial, fungal, and viral cultures and Gram and
genes, anaerobic cocci, Prevotella spp., Fusobacterium spp.,
giernsa stains
Veillonella spp.
Pe
--------------------------------------- 91
36
Orbital cellulitis:
- Hospitalize all children for IV antibiotics (ampicillm-sulbactam
IV]. Other options: Cefotaxime, cefuroxime, ceftriaxone,
clindamycin, or ticarcillin-clavulanate
--------------------------------------- 92
Ch.7:Central Nervous System Infections
Central Nervous
TABLE 7-1 Common Causes of Meningitis by Age
Neonates
39
6 weeks-Adulthood
System Infections
Group B Streptococcus
Streptococcus pneumoniae
Enterovirus
Borrelia burgdorferi
Mycobacterium tuberculosis
Inflammation of the meninges surrounding the brain
" Haemophilus influenzae type b meningitis is unusual in the neonate.
' Herpes simplex encephalitis should be considered in newborns with aseptic m
eningitis.
! Epidemiology
Bacterial meningitis is most common in infants and young
children
Pathogenesis
Dramatic decrease in incidence after immunization with
Major bacterial pathogens colonize the throat, then spread
Haemophilus influenzas type B (Hib) and 7-valent pneumococcal vaccines
through the bloodstream to the meninges
Contiguous infection or trauma can also deliver bacteria to the
Neisseria meningitidis meningitis occurs shortly after exposure
CSF space
to the organism
Enteroviral meningitis is seen in summer and fall
History
Fever, headache, vomiting, convulsions, altered mental status,
i Risk Factors
photophobia
Young babies may show nonspecific signs of sepsis (e.g., poor
Immune deficiency (hypogammaglobulinemia, splenic dysfeeding, somnolence)
function, complement deficiency); anatomic abnormality (CSF
fistula)
Tuberculous meningitis develops subacutely (usually over a
week or more)
Ask about exposures, travel, pretreatment with antibiotics,
Etiology (Table 7-1)
immunologic problems
Viral: Enteroviruses most common (ECHO, coxsackie); also
insect-borne viruses (e.g., equine encephalitis, West Nile);
Physical Examination
mumps; herpes simplex; others
Stiff neck (not seen in infants): Kernig sign (resistance to
extension of the knee); Brudzinski sign (involuntary flexion of
In immunocompromised patients: Listeria, Cryptococcus neoformans
the hip/leg when the neck is flexed)
Other infectious causes include syphilis, endemic fungi (e.g.,
Bulging fontanelle in infants; irritability
histoplasma), amebae
Focal neurologic signs suggest intracranial complication [perform CT/MRI before lumbar puncture (LP)]
Parameningeal: Infections contiguous to the meninges (brain
Petechial or purpuric rash in meningococcal or rickettsial
abscess, sinusitis, epidural abscess) can cause meningeal inflammation with negative cultures
infection
Noninfectious: Vasculitis (e.g., lupus), tumors, intrathecal injections, drugs [e.g., trimethoprim-sulfamethoxazole (Bactrim), nonAdditional Studies
steroidal anti-inflammatory drugs, intravenous immunoglobulin]
LP and spinal fluid examination (Table 7-2)
CSF culture, blood culture
38
Complete blood count, electrolytes, glucose
--------------------------------------- 93
ints Pediatric Infectious Diseases
Ch.1: Diagnostic Microbiology
Antimicrobial Susceptibility Testing
aking multiple specimens increases sensitivity (91.5%
5
T
In
M
A
p
I
system, ask when the plates were last examined for growth
- MBC is used to detect "tolerance"; defined as MIC/MBC
before determining whether to discontinue antibiotics for
ratio >1:32
"negative" cultures
- Clinical importance: Tolerance may make "cidal" antibiotics
act in a static manner
Serum cidal test (Schlicter test): Tests the bactericidal activity
FUN
GI
of patient's serum against a particular organism
- Clinical importance: Useful with nonfastidious organisms
assification of Fungi
(i.e., S. aureus) when issues arise regarding sites with diffi-
Cl
Ye
Mo
Cu
Cand
--------------------------------------- 94
40
41
Ecoli
Cefotaxime or imipenem/meropenem 3-6 wk
Viral
Mononudear:
Normal Slightly Negative
Streptococcus pneumoniasIf sensitive to penicillin: penicillin 10-14 d
hundreds
increased
If sensitive to cefotaxime, resistant to
TB
Mononudear;
Low
High
Negative
penicillin: cefotaxime
hundreds
If resistant to cefotaxime and penicillin,
Cryptococcal Mononudear:
Low
Normal
Negative
but sensitive to vancomycin:
few-100s
or high
cefotaxime + vancomycin rifampin
(Table 7-1)
Inflammation of the brain parenchyma; often accompanied by
- Empiric: In neonates, ampicillin plus cefotaxime (if grammeningeal involvement
negative rods on Gram stain, use carbapenem plus aminogly1 Epidemiology
coside). In older children, use vancomycin plus cefotaxime
(or ceftriaxone). For cephalosporin-allergic patients, consider
Herpes simplex virus (HSV) encephalitis: In neonates, perinaciprofloxacin, meropenem, or rifampin.
tal acquisition usually after primary maternal genital infection
- Definitive (Table 7-3)
(see Chapter 17). In older children, HSV encephalitis is most
- Add coverage but don't reduce it based on Gram stain results
commonly associated with reactivation
--------------------------------------- 95
42
tion
Etiology
Vasculitis; tumor; genetic and metabolic causes of cerebral
Viruses: Herpes simplex, insect-borne (Eastern and Western
dysfunction
equine, California, La Crosse, West Nile, Japanese), rabies,
enteroviruses, varicella, Epstein-Barr virus, others
Management
--------------------------------------- 96
44
Chest X-ray
Differential Diagnosis
Culture of abscess fluid (lumbar puncture is contraindicated;
Fever/headache: Meningitis, brain abscess, encephalitis, sinusitis
risk of herniation)
Spinal epidural abscess: Tumors, transverse myelitis, vertebral
a Differential Diagnosis
osteomyelitis
Aseptic meningitis associated with bacteremia: Search for
Brain abscess must be differentiated from other CNS infecparameningeal abscess
tions (meningitis, encephalitis) and from other intracranial
mass lesions
Management
Surgical drainage
Management
Antibiotics:
Control of intracranial pressure
- Intracranial: Vancomycin plus cefotaxime/ceftriaxone plus
Aspiration or surgical drainage, especially for large lesions with
metronidazole
mass effect
- Spinal: Vancomycin plus cefotaxime/ceftriaxone/ceftazidime
- Early cerebritis or small inaccessible lesions may resolve
Complications
with medical therapy
Antibiotic therapy
Intracranial: Subdural empyema may cause herniation. Both
- Empiric regimen: Cefotaxime/ceftriaxone plus metronidasubdural and epidural empyema may cause thrombosis of cerezole (+ Vancomycin)
bral veins and venous sinuses
- If associated with otitis or mastoiditis: Replace cefotaxime
Spinal: Spinal cord compression and paralysis
with ceftazidime
--------------------------------------- 97
46
47
--------------------------------------- 98
Ch. 8: Upper Respiratory Tract Infections
A. haemolyticum'. Scarlatiniform rash (prominent on extensor
Upper Respiratory
surfaces) usually in teenagers
Tract Infections
it Additional Studies
GAS rapid antigen detection studies: Sensitivity greater than
Susmita Pati, MD, MPH, NicholasTsarouhas, MD,
80%; specificity greater than 95%
and SamirS.Shah, MD
GAS culture: "Gold standard"; recommended when rapid studies are negative
"Monospot" (heterophile antibody) test: EBV diagnosis, but
Pharyngitis
not reliable if patient is younger than 5 years
EBV liters: "Gold standard"; necessary to diagnose EBV in chilEpidemiology
dren younger than 5 years
Atypical lymphocytosis and mild thrombocytopenia: Classic
Generally in children older than 3 years. Peaks in late winter/
CBC findings with EBV
early spring
Differential Diagnosis
Risk Factors
Stomatitis, peritonsillar or retropharyngeal abscess, dental
Day care attendance; crowded living conditions
abscess
S Etiology
Management
Bacterial: Group A Streptococcus (GAS), Group C and G strepGAS: 1) Penicillin V (first-line oral agent); 2) benzathine penitococci, Arcanobacterium haemolyticum, Neisseria gonorrhoeas,
49
--------------------------------------- 99
50
51
--------------------------------------- 100
52
53
2): Helium
--------------------------------------- 101
54
55
--------------------------------------- 102
56
57
R
M
ular sulcus
ming, diving, rhinitis medicamentosa
Mechanical obstruction: Choanal atresia, deviated septum, nasal
Drainage fistula may be present
polyps, foreign body, tumor, ethmoid bullae, encephalocele
Tympanic membrane inflamed or perforated
Chronic mastoiditis: Middle ear granulation tissue or polypoid
tiology
formations
Acute and subacute sinusitis
- Bacterial: 30% to 40% S. pneumoniae; 20% H. influenzae
Additional Studies
(nontypeable); 20% M. catarrhalis
Contrast-enhanced head CT to define extent of disease
--------------------------------------- 103
58
Si
Ac
Su
Co
Pe
Ep
Ep
--------------------------------------- 104
6
Cr
Fu
Gr
men) are usually present within 48 hours on Sabouraud dexIn theory, any yeast or mold can cause systemic disease in a comtrose or brain-heart infusion agar. In contrast to candidiasis,
promised host; the most commonly seen yeasts and molds are
blood cultures almost never positive in invasive aspergillosis
listed here.
- With some groups of molds and the filamentous bacteria
(Nocardia, Streptomyces, Actinomyces] biochemical tests
Candida spp.: C. albicans and C parapsilosis most common;
identify an isolate; such testing can take from 2 to 10 days
cause many types of infections, including dissemination to heart,
- Extent to which a mold should be identified (genus vs. genus
lung, liver, spleen, and kidney after catheter-related fungemia
and species) depends on site of isolation and immune status
Aspergillus spp.: Ubiquitous in environment; cause disease
of the host
(especially in sinuses and lungs) in cases of prolonged neuYeast:
tropenia, bone marrow and solid organ transplantation, and
- Pseudohyphae on Gram stain of surface lesions or aspirated
neutrophil dysfunction (e.g., chronic granulomatous disease)
fluids or GMS stain of biopsy specimens suggests C. albicans
Zygomycetes (Mucor, Absidia, Rhizopus): Diabetics and im- Microscopically, examine yeast for presence of capsule by
munosuppressed receiving steroids at highest risk
India ink (C. neoformans)
--------------------------------------- 105
60
Pathogenesis
examination
Local infection in lymph node may follow hematogenous
acterial Adenitis
spread of systemic infection or lymphatic drainage of infected
Empiric therapy
area
- PO: Cephalexin or dicloxacillin (first line), or clindamycin,
amoxicillin-clavulanate, cefuroxime, trimethoprim History
sulfamethoxazole (TMP-SMX), ciprofloxadn, or linezolid
Inquire about specific exposures, recent travel, dental prob- IV: oxacillin, cefazolin, clindamycin, ampicillm-sulbactam,
lems, and systemic symptoms
TMP-SMX, or vancomycin
Inquire about symptoms associated with compression of adjaonsider needle aspiration or incisional drainage if 1) not
--------------------------------------- 106
Chapter
Ch. 9: Lower Respiratory Tract Infections
- Rapid enzyme immunoassay for RSV and influenza:
O Lower Respiratory
Sensitivity, 85%; specificity, 97%
- Fluorescent antibody: Antigens of RSV, influenza, parainTract Infections
fluenza, and adenovirus
- Viral culture
SamirS.Shah,MD
Differential Diagnosis
Airway hypersensitivity to environmental irritants
Gastroesophageal reflux with pulmonary aspiration
Bronchiolitis
Anatomic airway abnormality
Cardiac disease with pulmonary edema
Acute viral lower respiratory tract infection
Other causes of wheezing
Epidemiology
Management
Peak occurrence in October through May
Extent of bronchiolar necrosis and speed of regeneration influ80% of infections occur in children younger than 2 years
ence recovery
Risk Factors
Usually self-limited: 3 to 7 days acute illness with slow recovery (2 weeks)
Risk factors for severe illness during bronchiolitis: Chronic
0.5% to 1% of patients require hospitalization; of these, 5%
lung disease (CLDJ; cystic fibrosis; congenital heart disease
previously healthy and 20% high-risk require intubation
(CHD); hematopoietic stem cell or organ transplantation; cel-
63
--------------------------------------- 107
64
65
pneumoniae
pneumoniae
CytomegalovirusChlamydia
Haemophilus
Streptococcus
Long term: Asthma more likely but cause/effect unclear
trachomatis
influenzae
pneumoniae
Listeria
Bordete/la
Acute Pneumonia
monocytogenes pertussis
Mycoplasma
Influenza
pneumoniae
viruses
I Additional Studies
Etiology
Chest radiograph (CXR) required for firm diagnosis
- Consider CXR: 1) Young children, 2) uncertain/severe diag30% to 40% bacterial; S. pneumoniae remains most common
nosis, 3) failure of therapy, or 4) recurrent infections
(Table 9-1)
Diagnostic clues
- Bacterial: Lobar/segmental consolidation or large pleural
Pathogenesis
effusion
Three main mechanisms of infection
- Staphylococcus aureus: Pneumatoceles (air-filled cavities
- Transient or chronic impairment of normal airway defenses
from alveolar rupture)
- Inhalation of large aerosol burden
- Viral or atypical: Diffuse or bilateral interstitial pattern
- Hematogenous seeding of the lung
- 10% of M. pneumoniae infections lobar, 20% with small
bilateral pleural effusions
History/Physical Examination
Blood cultures (uncomplicated pneumonia) positive in less
Fever, cough, labored breathing, chest or abdominal pain, vomthan 2% of outpatients but 7% to 10% of hospitalized children
iting, decreased activity
Transthoracic needle aspiration: Microbiologic yield 70% with
Tachypnea is the most reliable predictor of pneumonia in chilculture, polymerase chain reaction (PCR), and immunofluodren: Sensitivity, 50% to 85%; Specificity, 70% to 95%
rescence
Wheezing with pneumonia usually signifies viral or atypical
- Consider if immunodeficient or worsening pneumonia of
cause
unclear cause
Common findings:
NP cultures correlate poorly with cultures of lung tissue
--------------------------------------- 108
66
Co
History
macrolide,vancomycin
>5 years First line: Amoxiciliin or ampicillin'
Suspect pleural effusion if: 1) Pleuritic chest pain, 2) fever
more than 48 hours after starting treatment for pneumonia, 3)
Alternative: Cefotaxime, ceftriaxone, clindamycin, macrolide,
levofloxadn, vancomydn
clinical deterioration during treatment of pneumonia
' Add macrolide iff. trachomatis or 6. pertussis suspected.
Physical Examination
b Consider adding macrolide or doxycycline or using fluoroquinolone as monotrie
rapy to cover for
atypical organisms.
Dullness to lung percussion, diminished breath sounds over
affected lung
--------------------------------------- 109
68
Di
Ca
De
Management
Additional imaging: To assess for loculation (chest ultrasound
art antimicrobial therapy based on probable pathogens and
or CT); to delineate anatomy (chest CT)
adjust based on blood/pleural fluid culture results
Send pleural fluid studies (Box 9-1 and Table 9-3)
- Empiric: Ampicillin-sulbactam or cefotaxime + oxacillin
Pleural fluid eosinophilia: Parasites, TB, fungi, or hypersensitiv(vancomycin if methicillin-resistant S. aureus prevalent)
ity diseases
lassify pleural effusions based on CXR results
Consider pleural biopsy to detect tuberculous granulomas
- Size on decubitus CXR
St
Glucose
remove loculations/fibrinous peel
pH
- Thoracentesis (needle aspiration)
LDH
- Tube thoracostomy (TT; chest tube) with or without fibriGram stain
nolysis
Acid-fast stain
- Open decortication or video-assisted thoracoscopy (VATS)
Cultures"
with decortication
I
nitial surgical management based on size and character of
Sometimes
effusion: 1) Small: No surgical management; 2) Moderate:
Mycoplasma PCR
Thoracentesis or TT; 3) Large: TT or VATS; 4) Loculated:
Viral antigen immunofluorescence
Open decortication or VATS
Viral culture
Total protein
ubsequent management based on detection of empyema: 1)
Amylase
If initial thoracentesis reveals empyema, perform TT; 2) If
Cholesterol
inadequate drainage from TT, perform open decortication or
Cytology (to exclude malignancy)
VATS
Aerobic and anaerobic, consider mycobacterial and fungal.
plications
Com
R
Exudate
Empyema
>5000
>1 0,000
40-60
<40
pH
>7.3
7.2-7.3
<7.1
ny disease that affects the lung can cause pulmonary lymphadenopathy
LDH (IU/U
<200
200-1000
>1000
--------------------------------------- 110
70
71
Additional Studies
BOX 9-2 Infectious Causes of Pulmonary
Lymphadenopathy
CXR: Detects size and location of mass; detects calcifications;
prompts further imaging (CT or MRI) to define anatomy and
Bacterial
extent of disease
Mycobacterium tuberculosis
Chest CT: Demonstrates calcium; better for anterior and
Nontuberculous mycobacteria
Mycoplasma pneumoniae
middle mediastinal masses
Bartonella henselae
Chest MRI: Does not demonstrate calcium; better for posterior
mediastinal masses (usually neurogenic origin)
Bordetelia pertussis
Tuberculin skin testing (PPD)
Yersinia entemcolitica
Brucella spp.
Complete blood count findings (e.g., pancytopenia, eosinoFrandsella tularensis
philia) may suggest cause
Fungal
Differential Diagnosis
Histoplasma capsulatum
Coccidbides immitis
Chronic inflammation: Bronchiectasis, cystic fibrosis, lung
Pamcoaidioides brasiliensis
abscess
Blastomyces dermatitidis
Malignancy: Hodgkin lymphoma, non-Hodgkin lymphoma,
Cryptomccus neoformans
leukemia
Other: Chronic granulomatous disease, Langerhans cell histioOther
cytosis, sarcoidosis, Castleman disease
H!V
Epstein-Barr virus
Management
Toxaplasma gondii
Lymph node biopsy if: 1) Other tests do not reveal cause; 2)
size increases over 2 weeks or persists for more than 4 weeks;
3) malignancy is suspected
m Pathogenesis
Findings that suggest abnormal mediastinal lymph nodes: 1)
mplications
Lymph nodes present where none usually seen; 2) size greater
Related to cause of mediastinal adenopathy
than 1.5 cm; 3) lymph node morphology reveals calcification,
cavitation, caseation, or rim enhancement
History
Findings from underlying cause or compression of adjacent
structures. Inquire about:
- Cough, wheezing, hemoptysis, dysphagia, hematemesis
- Facial swelling, headaches, epistaxis, tinnitus
- Hoarse voice, symptoms of spinal cord compression
Physical Examination
Determine number, location, and size of lymph nodes outside
the chest
Findings from underlying cause or compression of adjacent
structures. Adjacent structures include:
- Trachea, bronchi, esophagus
- Superior vena cava, lymphatic vessels
- Recurrent laryngeal and phrenic nerves, sympathetic ganglia,
Co
ribs, vertebrae
--------------------------------------- 111
Chapter
Ch. 10: Cardiac Infections
73
Pathogenesis
Turbulent blood flow, regurgitant jet, or foreign body abrades
Cardiac Infections
endocardial surface
Endocardial erosion allows platelet-fibrin thrombi to form
Bacteria or fungi implant on thrombi resulting in vegetation
Robert S. Baltimore, MD
formation
Prosthetic heart material, cut surfaces, and foreign bodies allow
bacteria to adhere
Endocarditis
History/Physical Examination (Box 10-1)
Key features: Change in heart murmur, new or worsening heart
Endocarditis: Infection on the endocardial surface of the heart
including the heart valves
failure, peripheral septic emboli, or new neurologic findings
Infections on the endothelial surface of blood vessels may act
as "endocarditis"
BOX 10-1 Symptoms, Signs, and Laboratory Findings
Epidemiology
Associated with Infective Endocarditis in Children
Estimated incidence, 1.7 to 4 cases per 100,000 population per
Symptoms
year in developed countries
Fever
In children, mostly a complication of congenital heart disease
Malaise
(CHD)
Anorexia/weight loss
Heart failure
Arthralgta
Risk Factors
Chest pain
CHD: Especially tetralogy of Fallot and ventricular septal
Neurologic symptoms"
defects
Gastrointestinal symptoms
Surgically repaired CHD using patches, grafts, or artificial
valves
Signs
Others: Mitral valve prolapse; atherosclerosis [adults); intraFever
venous drug use; indwelling central vascular catheters; rheuSplenomegaly
matic heart disease (once common, now rare)
Petechiae
Embolic phenomenon
New or changed murmur
Etiology
Clubbing
Bacteria: Viridans streptococci (most common at all ages);
Osier nodes
enterococci; Staphylococcus aureus; coagulase-negative staphyRoth spots
Janeway lesions
lococci; hemolytic streptococci, groups A, B (in neonates and
Splinter hemorrhages
elderly), C, G, D Streptococcus; Streptococcus pneumoniae; gramConjunctival hemorrhage
negative enteric rods (uncommon); HACEK organisms (Haemophilus aphrophilus, Actinobacillus actinomycetemcomitans,
Laboratory Findings
Cardiobacterium hominis, Eikenella corrodens, and Kingella
Positive blood culture
kingae]
Elevated ESR
Fungi: Candida species, Aspergillus species, Cryptococcus neoAnemia
formans
Positive rheumatoid factor
' Others: Coxiella burnetii (Q fever), chlamydiae, culture-negative
Hematuria
endocarditis
" Such as focal neurologic deficit and aseptic meningitis.
72
--------------------------------------- 112
74
75
--------------------------------------- 113
76
Inflammatory condition involving the myocardium; pericardium and endocardium sometimes involved. Dilated carAdditional Studies
diomyopathy is a manifestation of chronic myocarditis
Chest radiograph: Enlarged cardiac silhouette
Two-dimensional and M-mode echocardiography: Detects
Epidemiology/Risk Factors
pericardial fluid
Myocarditis follows 34.6 per 1000 coxsackie virus infections
Pericardiocentesis: Diagnostic and therapeutic
Certain agents vary geographically: For example, Chagas dis- Send for WBC and differential counts, glucose, protein, and
cytology
ease (South America) and Lyme disease (East and West Coast,
- Gram stain, acid-fast stain, and silver stain
Northern Midwest in United States)
Risk factors include young age (particularly newborns) due to
- Culture for viruses, bacteria (aerobic and anaerobic), fungi,
lack of protective antibody; immunocompromised including
and mycobacteria
HIV
Viral cultures [and polymerase chain reaction (PCR) if available] from nasopharynx, throat, stool, and pericardial fluid
Blood cultures for bacteria and fungi
Etiology
Serology (paired sera) for viruses, fungi, and mycoplasma
Common: Enteroviruses (particularly coxsackie viruses B3 and
Pericardial biopsy best for Mycobacterium tuberculosis
B4), adenoviruses
ECG shows nonspecific ST-T wave changes (elevation or
- Formerly "idiopathic" cases probably due to coxsackie virus
depression). There may be low-voltage QRS complexes, PR
based on molecular probes
segment deviation (early), flat or inverted T waves (late)
Less common: Influenza A and B viruses, CMV, HIV, and Lyme
disease
Differential Diagnosis
Rare: Acute rheumatic fever, measles, varicella, CoryneNoninfectious causes of pericarditis: Collagen vascular disbacterium diphtheriae (toxin mediated), Neisseria meningitidis,
S. aureus, Haemophilus influenzae type b
eases; rheumatic fever; sarcoidosis; drugs (hydralazine, phenytoin); injury (myocardial infarction, chest trauma); metabolic
(hypothyroidism, uremia); neoplastic; familial Mediterranean
Pathogenesis
fever; Kawasaki disease
Myocardium damaged by direct myocyte invasion followed by
--------------------------------------- 114
78
Additional Studies
Cultures: viral (nasopharynx, throat, urine, stool, CSF); bacterGastrointestinal
ial [blood, CSF, pericardia!)
Tract Infections
Chest radiograph: Cardiac enlargement and pulmonary edema
Endomyocardial biopsy for culture, histopathology, and PCR
for viruses and Borrelia burgdorferi
Petar Mamula, MD, Raman Sreedharan, MD, MRCPCH,
- PCR detects viral genome weeks to months after infection
and Kurt A. Brown, MD
Use Dallas Criteria for histopathologic analysis of stage of
inflammation in biopsy
Elevated WBC, ESR, creatine phosphokinase (MB fraction),
and cardiac troponin T
Gastroenteritis
ECG: Prolonged PR interval, low-voltage QRS (less than 5 mm),
Acute diarrhea: Abrupt increase of fluid content in stool (more
premature atrial and ventricular complexes, ST- and T-wave
than 10 mL/kg/d). Frequency of bowel movements ranges
--------------------------------------- 115
8
small numbers; if present in moderate or large numbers, treatpolysaccharide antigen, high sensitivity (99%); usually sent
from CSF and blood in conjunction with culture
ment should be implemented
H. capsulatum: Antigen test commonly used; detects heat-stable
elminths (worms)
polysaccharide in serum, urine, and cerebrospinal fluid (CSF);
Nematodes (roundworms): Intestinal and blood forms; sepaurine 99% sensitive for disseminated disease but less than 50%
sensitive for local pulmonary disease; always confirm with culrated by how they enter the host:
ture since antigen test cross reacts with other dimorphic fungi.
- Humans ingest ova: Enterobius vermicularis (pinworm),
Trichuris trichiura (whipworm), Ascaris lumbricoides (human
Histoplasma urinary antigen test best for patients unable to
roundworm)
mount sufficient antibody response (e.g., HIV infection)
- Humans ingest larvae: Trichinella, Anisakis
Antibody detection commonly used for blastomycosis, coccid- Larvae burrow into skin from soil: Hookworm, Strongyloides
ioidomycosis, histoplasmosis, and paracoccidioidomycosis.
- Humans acquire via insect bite: Microfilaria (Wuchereria
bancrofti, Loa loa, Mansonella spp.)
Antif ungal Susceptibility Testing
- Animal nematodes that accidentally infect humans: AncyloStandardized methods now available for quantitative antifunstoma brasiliense (dog and cat hookworm penetrates human
gal susceptibility testing of yeast and some molds, but clinical
skin to cause cutaneous larva migrans) and Toxocara canis
correlation data are lacking
and T. cati (dog and cat roundworms; humans ingest ova to
cause visceral or ocular larva migrans)
Cestodes (tapeworms; flat worms): Come in intestinal and
PARASITES
tissue forms
- Intestinal infection in humans after ingestion of infected fish
Classification of Parasites
(Diphyllobothrium latum), arthropods (Hymenolepis nana,
Hymenolepis diminuta), pork (Taenia solium), or beef (T. sagiProtozoa
nata)
Single-celled organisms and some have two physical forms: An
- Tissue infection in humans after ingestions of eggs from
adult form called a trophozoite and a "resting" form called a
infected human (T. solium) or sheep (Echinococcus granulocyst. Divided into six classes (Table 1-3)
sus) stool
--------------------------------------- 116
80
^^^^^^^^^^^^
81
IPIPIPP
Ampicillin,cefotaxime,
immunodeficiency,
ciprofloxadn, azithromycin
Determine duration of illness, stooling pattern (frequency,
dissemination
volume, blood/mucus), travel and ingestion history (see
Shigella spp. Dysentery
Ceftriaxone,azitrtromycin,
"Epidemiology/Risk Factors"), hydration status
fluoroquinolones, TMP-SMX
Other symptoms: Fever, emesis, abdominal pain, rash, tenesmus
Vibrio choleraeTreatment decreases
illness duration
Physical Examination
Yersinia
CiprofloxadnJMP-SMX,
tetracyclines
Sepsis, immunodeficiencyCefotaxitne,TMP-SMX,
--------------------------------------- 117
82
momydn,quinacrine
BlastocystisWorldwide
Metronidazole Furazolidone,
History/Physical Examination
hominis
(20-35 mg/kg
tinidazole
Travel and dietary history
dividedTID x 10 d)
Abdominal pain, diarrhea, tenesmus, bloating, flatulence
Cryptospo-Countries with higNitazoxanide(1QOhAzithromyd-n +
Fever, emesis, anorexia
ridium
AIDS prevalence 200 mg BID) (therapparomomyciyn
Wheezing (Strongyloides stercoralis, Ascaris lumbricoides)
parvum
only needed for
Muscle pain or skin rash {Trichinella spiralis)
patients with AIDS)
Pruritis ani (often nocturnal) (Enterobius vermicularis)
Isospora S.America, AfricaTrimethopri,m Pyrimethamine
Local skin reaction at the site of larvae penetration (S. stercobelli
SEAsia
(5 mg/kg)(50-75 mg/day) +
ralis, Ankylostoma duodenale)
sulfamethoxazolefolinkacid
Failure to thrive and growth impairment with chronic infections
(25mg/kg)BIDx
Evaluate for dehydration, abdominal obstruction or mass
83
7-10 d)
CyclosporaDeveloping countrieSames as for
Additional Studies
cayetanensis
Isospora belli
Strongylo-Tropics, easternAlbendazole
Thiabendazole (25 mg/
Stool for ova and parasites (see Chapter 1): Several not found
idesstmo- Europe, Australia(400mgBIDx3d),,kg BID x 2-3 d)
on standard ova and parasite testing {Cryptosporidium parvum,
mlis
southern US
ivermectin(20Qig/
Cyclospora cayetanensis, and Microsporidia species)
kg/dx1-2d)
Duodenal aspirate (during endoscopy or swallowed string test)
TrichinellaWorldwide in Mebendazole (200 mg
Tape test (E. vermicularis)
spiralis communities conTID-x 3d, followed
Mucosal biopsy (G. lamblia, S. stercoralis, C. parvum, Entasuming pork meaby400mgTIDx10dt )
moeba histolytica)
Ascaris Prevalence highesAlbendazolte (200Levamisol-e (5 mg/kg
Enzyme-linked immunosorbent assay (ELISA) for giardiasis,
lumbricoidesin developing worl400d mg single dosesingl)e dose), piperamebiasis, cryptosporidiosis
(roundworm)
or mebendazole azine citrate, pyrantel
Serology for helmintic infections (S. stercoralis, trichinosis)
(500 mg single dosepamoat)e
Serum eosinophilia
AnkylostomaAfrica, Asia, AustraliaMebendazol,e (10Albendazol0e (400 mg
Muscle biopsy (T. spiralis}
duodenale southern Europe mgBIDx3d)
single dose)
(hookworm)
Management
Necator Central and SouthMebendazole (10Albendazol0e (400 mg
See Table 11-2.
americanusAmerica, SEAsia,mgBIDx3d)
single dose)
(hookwormPacifi)c
Taenia
Worldwide, morePraziquante inl (5-1Niclosamide(50mg0/
Complications
saginata Central Africa mg/kg single dosek)g single dose)
Hepatic abscess (amebiasis)
Seizures (Taenia solium)
Pneumonitis, myocarditis, encephalitis (T. spiralis)
--------------------------------------- 118
84
85
Echinococcus granulosus
Cellular hepatocyte damage may occur due to direct cytopathic
Schistosoma species
Oonorchii sinensis (liver fluke)
effect or, more commonly, due to immune-mediated injury
Fasciola hepatica
Leishmania donovani
History/Physical Examination
Toxocaracanis
Fever, fatigue, anorexia
Jaundice, scleral icterus, abdominal pain, pruritus, diarrhea,
Fungi
dark urine
Candida species
Histoplasma capsulatum
Hepatomegaly (often painful), splenomegaly (with viruses)
Aspergillus species
Rash (e.g., syphilis, Lyme disease, hepatitis B)
(ryptowccus neoformans
Additional Studies
Coccidioidesimmitis
Penidllium marneffei
Elevated alanine aminotransferase (ALT) or aspartate aminoTrkhosporon aitaneum
transferase (AST)
ALT (mainly present in the liver) is more specific for liver disease than AST
Elevated bilirubin, alkaline phosphatase, and y-glutamyltransSerologic tests for hepatitis viruses (Table 11 -3)
ferase (GGT) suggest cholestasis
Abdominal ultrasound of the liver, biliary tree, and spleen to
Liver synthetic function: Serum albumin level, prothrombin
diagnose anatomic abnormalities
time (FT) and partial thromboplastin time (PTT)
Percutaneous liver biopsy may be required for diagnosis
--------------------------------------- 119
86
87
Virus
source of infection
Hepatitis A HAIgM
N/A
Secondary bacterial peritonitis: Peritoneal infection secondary
HAigG
N/A
to an abdominal source, such as perforation of an abdominal
Hepatitis K HBsAg
HBsAb
HBcAb
+ (lgM)
+ (lgG)
+ OgG)
Hepatitis C HCVPCR
Epidemiology/Risk Factors
HCVAb
Hepatitis D HDV Ag
Risk factors: Appendicitis; chronic renal failure (occurs in up to
HOVigM
17% of patients with nephrotic syndrome); liver failure; periHOVlgG
toneal dialysis; ventriculoperitoneal (VP) shunt
Hepatitis E HE Ag
N/A
Also occurs in 2% to 17% of processes that perforate intestine
HEIgM
N/A
(e.g., trauma, necrotizing enterocolitis, volvulus)
HDVPCR
N/A
Etiology
Common: Streptococcus pneumoniae (previously healthy chilDifferential Diagnosis
dren), S. aureus (dialysis catheters, VP shunts), gram-negative
Cholecystitis, drug/toxin-induced, autoimmune hepatitis, Wilson
enteric bacilli (cirrhosis), coagulase-negative staphylococci
disease, CXj-antitrypsin deficiency, inborn metabolic errors, scle(VP shunts)
Less common: Candida spp., Neisseria meningitidis, Haemorosing cholangitis, hepatic malignancy, vascular disorders (e.g.,
philus influenzae type b (unimmunized)
Budd-Chiari), others (Crohn)
Management
Pathogenesis
Antibiotic treatment of bacterial, parasitic, and fungal hepatitis
Primary SBP: Hematogenous or lymphatic spread to peridepends on the individual organism and severity of disease
toneum
Most viral hepatitides are self-limited (e.g., CMV, EpsteinSecondary bacterial peritonitis: Intestinal perforation
Barr, hepatitis A and E)
--------------------------------------- 120
88
89
iary atresia)
- Liver transplantation (occurs in 10% of transplants, usually
in first 2 months)
- Intrahepatic cholestatic liver diseases (e.g., Alagille syndrome)
Etiology
Common: E. coli, Klebsiella spp., Enterococcus, anaerobes (10%
to 30% of cases)
--------------------------------------- 121
Chapter
Ch. 12: Genitourinary Tract Infections
BOX 12-1 Causes of Urinary Tract Infection
Common
Lcolis
ftofeusspp."
Klebsiellaspp.
Ron Keren, MD, MPH and David Rubin, MD, MSCE
P.aeruginosa
Enterocoausspp.
S.saprophyticus
Urinary Tract Infection
Less Common
Urinary tract infection (UTI): Infection of the bladder (cystitis,
Group B streptococci
lower tract) or kidneys (pyelonephritis, upper tract)
Salmonella spp,
SWjeffaspp.
Epidemiology
(ampylobacterspp.
Prevalence in febrile children without fever source: Ages 2 to
Rare
24 months = 5%
- Gender is an important variable in those older than 3
months (e.g., prevalence at ages 12 to 24 months: boys =
Anaerobes
91
Fungi
1.9%; girls = 8.1%)
M.tuberculosis
Protozoa
Risk Factors/ Etiology (Box 12-1)
Adenovirus
White race (in school-aged girls); uncircumcised phallus (5 to
' Accounts for 70% to 90% of UTls.
20 times increased risk); sexually active female; male sex
* Usually in boys older than 1 year.
(younger than 3 months); female sex (older than 3 months);
indwelling urinary catheter; vesicoureteral reflux (VUR)
Pathogenesis
GI bacteria colonize periurethral mucosa (mediated by host
of pyelonephritis have bacteria isolated from kidneys by
and bacterial adhesion factors) and then ascend to bladder and
ureteral catheterization.
kidneys
Meatal erythema or abnormalities, costovertebral angle or
VUR (present in 30% to 50% with UTI) increases risk of
suprapubic tenderness
pyelonephritis
Additional Studies (Table 12-1)
History/Physical Examination
Urine dipstick positive (dipstick positive if > trace leukocyte
Infants: Fever, irritability, decreased feeding/activity, vomiting,
esterase or positive nitrite): Sensitivity = 80%; specificity = 97%
jaundice (neonates)
Urine dipstick positive or 5 or more bacteria per high-powered
Pre school age: Fever, abdominal pain, enuresis, foul-smelling
field by microscopy: Sensitivity = 85%; specificity = 87%
urine
School age: Dysuria, frequency, urgency, hesitancy, hematuria,
Differential Diagnosis
back/abdominal pain
Urethritis, vaginitis, cervicitis, prostatitis, foreign body, nephroFever in a child with a positive urine culture reliably identifies
lithiasis, renal abscess, vaginovesical fistula, enterovesical fistula
pyelonephritis (sensitivity = 84%, specificity = 92%)
Exam findings do not reliably distinguish cystitis from
Management
pyelonephritis. Up to 25% of children without signs/symptoms
Well-appearing children with a urinalysis suspicious for UTI
90
require antibiotics while awaiting confirmatory culture results;
--------------------------------------- 122
92
kidney
Supra pubic aspirateAny number'
Perinephric abscess: Abscess outside
Transurethral
>100,000
renal fascia
catheterization
10,000-100,000
1000-10,000
>99%
the kidney but within the
95%
Probable
Possible (repeat)
Epidemiology
<1000
Unlikely
Uncommon but exact incidence unknown; affects all age
Clean void
3 Specimens >100,000
1 Specimen >100,000
groups; no gender preference
10,000-100,000
Possible (repeat)
<10,000
Unlikely
Risk Factors
Urinary tract: Infection, VUR, obstruction, neurogenic bladder,
' Colony count of pure culture.
'If gram-negative bacilli.
nephrolithiasis, tumor, polycystic kidney disease, peritoneal
Adapted from American Academy of Pediatrics. Practice parameter: the diagnosis,
treatment, anddialysis
evaluation of the initial urinary tract infection in febrile infants and young
children.ftrf/am'a Other conditions: Bacteremia; abdominal or urinary tract surgery; immunodeficiency; renal trauma; diabetes mellitus
1999;103:843-852.
Etiology
Common: Enterobacteriaceae (primarily Escherichia colt);
Staphylococcus aureus
Less common: Pseudomonas spp.; Enterococcus spp.; coagulasesome evidence that these patients can be treated safely as outnegative staphylococci (prosthetic device related); Streptococcus
patients with oral antibiotics
spp.; Candida spp.
Children 2 to 24 months of age with suspected UTI assessed as
Rare: Actinomyces; anaerobic organisms; Mycobacterium tubertoxic, dehydrated, or unable to retain oral intake require par-
culosis
enteral antibiotics and fluids
Empiric antibiotic therapy:
Pathogenesis
- IV: Ampicillin plus gentamicin (combined) or cefotaxime
Intrarenal abscess: Usually hematogenous spread (Staphylococcus
(monotherapy)
aureus}; occasionally complication of ascending UTI (Entero- PO: Ceftibuten, TMP-SMX, cephalexin, or amoxicillinbacteriaceae)
clavulanate
Duration of therapy: 10 to 14 days
Perinephric abscess: Usually complication of ascending UTI or
direct extension of intrarenal abscess; occasionally hematogeFor children 2 to 24 months with UTI, the AAP recommends 1}
nous spread
renal ultrasound to identify congenital or acquired urinary
tract abnormalities (e.g., dysplasia, hydronephrosis); 2] voiding
History
cystourethrogram (VCUG) to identify VUR, and, in boys, posterior urethral valves
One to three weeks of malaise, lethargy, weight loss, nausea,
vomiting, fever, and costovertebral angle tenderness or referred
Renal cortical scintigraphy 99mTechnitium-dimercaptosucto back, abdomen or hip, UTI symptoms (if antecedent UTI)
cinic acid (DMSA) scan identifies acute pyelonephritis and
Consider abscess if: 1) Failed UTI treatment; 2) fever without
renal scarring. Not routinely required
source after urinary or abdominal surgery; and 3) fever and urinary tract obstruction
Complications
Bacteremia (18% risk if 1 to 3 months old; but rare if older
Physical Examination
than 1 year); perinephric abscess or stones; renal scarring causPalpable renal mass (5% of cases, mostly infants), scoliosis with
ing hypertension and end-stage renal disease
splinting of affected side, pain on bending to contralateral side
--------------------------------------- 123
94
95
space; rupture into abdominal or pulmonary space; hematogeCervical culture for N. gonorrhoeae and C. trachomatis
nous spread to other sites
Nucleic acid amplification (rapid detection with PCR/LCR)
techniques replacing culture as tests of choice
Pelvic Inflammatory Disease and Cervjcjtis
Consider testing for other STDs including HIV and syphilis
Exclude pregnancy (including ectopic)
Pelvic inflammatory disease (PID): Ascending spread of
Abdominal/pelvic ultrasound: Fluid-filled/thick fallopian tubes;
microorganisms up the genitourinary tract. Distinguish PID
tubo-ovarian abscess
from uncomplicated cervicitis (vaginal discharge and cervical
findings without abdominal pain)
Differential Diagnosis
Gynecologic causes: Pregnancy (including ectopic), ovarian
Epidemiology/Risk Factors
cyst, ovarian torsion, ovarian mass, dysmenorrhea, endometrio20% of all cases occur in adolescents; 1 in 8-10 sexually active
sis, mittelschmerz (ovulatory pain)
are affected
Urinary tract causes: Urinary tract infection, nephrolithiasis
--------------------------------------- 124
96
for STDs:
Consider hospitalization when poor adherers, young adoles- Vaginal/rectal swab: Culture for N. gonorrhoeae and C. tracents, vomiting, ovarian abscess, and ectopic pregnancy or
chomatis (rapid detection techniques not validated in prepuappendicitis not yet excluded
bertal children and should not be used in this setting); vaginal
Educate regarding STD prevention
swab also for Gram stain and wet mount for T. vaginalis
Uncomplicated Cervicitis
- Throat culture: N. gonorrhoeae
Ceftriaxone or ciprofloxacin (one dose) plus azithromycin
- Serum: HIV antibodies (at time 0, 2, and 6 months), rapid
plasmin reagin (syphilis), hepatitis B surface antigen, and
(one dose) or doxycycline (BID for 7 days)
Management
Complications
N. gonorrhoeae: Ceftriaxone (one dose)
Ectopic pregnancy, infertility, recurrent infection, tubo-ovarian
. trachomatis: Azithromycin (one dose)
abscess, chronic abdominal pain, and perihepatitis (Fitz-Hugh
Syphilis: Penicillin
and Curtis syndrome)
T. vaginalis: Metronidazole (3 days or one dose depending on
Infectious Diseases inithe Sexually Abused Child
Hepatitis B: Vaccinate if unimmunized
HIV: Consider postexposure prophylaxis (see Chapter 21)
Epidemiology/Risk Factors
Medicolegal Interpretations
Low prevalence of STDs but certain situations warrant screening:
- Children with symptomatic infection
In a child evaluated for suspected abuse, an STD diagnosis sup- Another STD diagnosed in the same child
ports the investigation
- Perpetrator or another sibling in the household found to
Occasionally, an STD is diagnosed but sexual abuse in not suspected. Potential problems for interpretation of test results
have an STD
include: 1) Many STDs vertically transmitted during birth; 2)
- Assault has occurred within 24 to 48 hours and postexposure prophylaxis is considered
some pathogens (HPV, C. trachomatis} may have long incuba- Clear evidence of injury or transfer of secretions from the
tion periods; 3) HSV and T. vaginalis can be spread by autoinoculation or innocent transmission by close household contacts
perpetrator to the victim
- All girls staged Tanner III or greater
Etiology
N. gonorrhoeae, C. trachomatis, herpes simplex virus (HSV),
HIV, syphilis, hepatitis B or C, Trichomonas vaginalis, human
papilloma virus (HPV)
--------------------------------------- 125
Ch. 13: Skin and Soft-Tissue Infections
99
--------------------------------------- 126
xvi
Contributors
Contributors
xvii
Susmita Pati,MD, MPH
John R. Schreiber, MD, MPH
Assistant Professor of Pediatrics
Ruben Bentson Professor and Head Department of Pediatrics
University of Pennsylvania School of Medicine
--------------------------------------- 127
Reviewers
Foreword
The disciplines of infectious diseases is a holdout from times past
compared with other subspecialties. Clinical skills are not supplanted by technology and procedures. Honing in on cardinal
symptoms and the timeline, cadence and context of illness; judgRicky Choi
ing the child's sense of well being; seeking clues on examination
Class of 2004
to target organ systems involved; cataloging exanthems and enanMedical University of South Carolina
thems; confirming the clinical suspicion with a few well-chosen
Charleston, South Carolina
Resident, Medicine-Pediatrics
Duke University Medical Center
Durham, North Carolina
Derek Wayman, MD
Resident, Family Practice
University of North Dakota
Grand Forks, North Dakota
--------------------------------------- 128
Acknowledgments
Blueprints have become the standard for medical students to use
The conceptual basis for this book arose from my teaching expeduring their clerkship rotations and sub-internships and as a
riences at The Children's Hospital of Philadelphia. The housestaff
review book before taking the USMLE Steps 2 and 3.
and medical students asked insightful questions (occasionally at
Blueprints initially were only available for the five main spe3 a.m.) that provided the initial stimulus for this book. I am incialties: medicine, pediatrics, obstetrics and gynecology, surgery,
debted to them for this inspiration.
and psychiatry. Students found these books so valuable that they
I thank my colleagues who have contributed their expertise in
asked for Blueprints in other topics and so family medicine, emerwriting chapters for this book. 1 would also like to thank my
gency medicine, neurology, cardiology, and radiology were added.
Department Chair, Dr. Alan Cohen, and my Division Chiefs, Drs.
In an effort to answer a need for high yield review books for
Louis Bell and Paul Offit, for creating an environment supportive
the elective rotations, Blackwell Publishing now brings you
of intellectual pursuits. During the years, I have learned from
Blueprints in pocket size. These books are developed to provide
many other excellent clinicians. Their dedication to teaching and
students in the shorter, elective rotations, often taken in 4th year,
commitment to patient care are attributes I strive to emulate.
with the same high yield, essential contents of the larger Blueprint
Without them, this accomplishment would not be possible.
books. These new pocket-sized Blueprints will be invaluable for
There is not enough space to list you all by name but know that
those students who need to know the essentials of a clinical area
but were unable to take the rotation. Students in physician assis1 consider learning from you a privilege. Marie Egan, Victor Morris,
tant, nurse practitioner, and osteopath programs will find these
Patrick Gallagher, Stephen Ludwig, Bill Schwartz, and Istvan Seri
books meet their needs for the clinical specialties.
deserve special recognition for sharing their wisdom and experiFeedback from student reviewers gave high praise for this
ence as I embark on my career.
addition to the Blueprints brand. Each of these new books was
--------------------------------------- 129
Abbreviations
xxiii
C
XR Chest radiograph
D
CF Dichlorohydrofluorescein
Abbreviations
DOS Dose dependent susceptible
DFA Direct fluorescent antibody
DHR Dihydroxyrhodamine 123
DIC Disseminated intravascular coagulation
d
s Double stranded
DTP Diphtheria-tetanus-pertussis (vaccine)
5-FC 5-fluorocytosine
EBV Epstein-Barr virus
AAP American Academy of Pediatrics
ECG Electrocardiogram
Ab Antibody
ABPA Allergic bronchopulmonary aspergillosis
EEE Eastern equine encephalitis virus
AFB Acid-fast bacillus
EEC Electroencephalogram
Ag Antigen
EIA Enzyme immunoassay
ELISA Enzyme-linked immunosorbent assay
ALC Absolute lymphocyte count
EM Erythema migrans
ALT
EMB
ANC
ESR
AOM
--------------------------------------- 130
xxiv
Abbreviations
Abbreviations
xxv
Ig Immunoglobin
PICC Peripherally inserted central catheter
IgA Immunoglobulin A
PID Pelvic inflammatory disease
IgE Immunoglobulin E
PPD Purified protein derivative (for tuberculin skin test)
IgG Immunoglobulin G
PT Prothrombin time
IgM Immunoglobulin M
PTLD Posttransplantation lymphoproliferative disorders
INH Isoniazid
PIT Partial thromboplastin time
IUGR Intrauterine growth retardation
RIG Rabies immune globulin
IVIG Intravenous immunoglobulin
RMSF Rocky Mountain spotted fever
JCAHO Joint Commission on Accreditation of Healthcare
RPR Rapid plasma reagin
Organizations
RSV Respiratory syncytial virus
JRA Juvenile rheumatoid arthritis
RTI Reverse transcriptase inhibitor
KOH Potassium hydroxide
sAb Surface antibody
LCMV Lymphocytic choriomeningitis virus
sAg Surface antigen
LCR Ligase chain reaction
SARS Sudden acute respiratory syndrome
LDH Lactate dehydrogenase
SBE Subacute bacterial endocarditis
UP Lymphocytic interstitial pneumonitis
SBI Serious bacterial infections
LP Lumbar puncture
SBP Primary spontaneous bacterial peritonitis
Mac- No growth on MacConkey agar
VL Viral load
--------------------------------------- 131
Blueprints Q&A Step 2 and
Blueprints Q&A Step 3
BLUE
PRINTS
Review individual content areas as needed
and be fully prepared for Steps 2 & 3!
atric
QSA Step 2
Pedi
ctious
Psychiatry
ases
Q&A Step 2
QSAStepa
Step 3 boards
Full answer explanations for
correct and incorrect answers
Increased number of figures
NEW! Abbreviations
Med/cine
Obstetrics &
Gynecology
Blackwell
Publishing
NEW! Convenient pocket size
In Bookstores Now!
or call: 1-800-216-2522
www.blackwellmedstudent.com CODE: QAstep2304
--------------------------------------- 132
2005 by Blackwell Publishing
Blackwell Publishing, Inc., 350 Main Street, Maiden, Massachusetts
02148-5018, USA
Blackwell Publishing Ltd, 9600 Garsington Road, Oxford OX4 2DQ, UK
Blackwell Publishing Asia Pty Ltd, 550 Swanston Street, Cariton, Victoria
Dise
3053, Australia
All rights reserved. No part of this publication may be reproduced in any
form or by any electronic or mechanical means, including information storage and retrieval systems, without permission in writing from the publisher,
This book is dedicated to my grandparents
except by a reviewer who may quote brief passages in a review.
Shantilal and Savitaben Shah and Ramanlal and Savitaben Sheth
04 05 06 07 5 4 3 2 1
ISBN: 1-4051-0402-3
Library of Congress Cataloging-in-Publication Data
Blueprints pediatric infectious diseases / [edited by] Samir S. Shah. 1st ed.
p. ; cm.
(Blueprints)
Includes index.
ISBN 1-4051-0402-3 (pbk.)
1. Communicable diseases in children Outlines, syllabi, etc.
2. Communicable diseases in children Handbooks, manuals, etc.
[DNLM: 1. Communicable Diseases Child Handbooks.
2. Communicable Diseases Child Outlines. 3. Communicable Diseases
Infant Handbooks. 4. Communicable Diseases Infant Outlines.
5. Pediatrics methods Handbooks. 6. Pediatrics methods Outlines.
WS 39 B658 2005] I. Title: Pediatric infectious diseases. II. Shah, Samir S.
III. Series.
RJ401.B5842005
618.22'9-dc22
2004013358
A catalogue record for this title is available from the British Library
Acquisitions: Beverly Copland
Development: Selene Steneck
Production: Debra Murphy
Cover design: Hannus Design Associates
Interior design: Mary McKeon
Illustrations: Electronic Illustrators Group
--------------------------------------- 133
Contents
Contributors x
"
Reviewers xw
"
Foreword x/x
Preface xx
Acknowledgments xx/
Abbreviations xx
"
Chapter 1: Diagnostic Microbiology 1
Karin L McGowan, PhD, F(AAM)
and Deborah Blecker Shelly, MS
Bacteria 1
- Laboratory Methods Used to Identify Bacteria 1
- Antimicrobial Susceptibility Testing 4
- Blood Cultures 4
Fungi 5
- Classification of fungi 5
- Laboratory Methods Used to Identify Fungi 7
- Antifungal Susceptibility Testing 8
Parasites 8
- Classification of Parasites 8
--------------------------------------- 134
viii
Blueprints Urology
Contents
Chapter 4: Antifungal Agents 23
- Pleural Effusion 67
Theoklis E.Zaoutis,MD
- Pulmonary Lymphadenopathy 69
- Mechanisms of Antifungal Action and Resistance 23
xiv
Jeffrey M. Bergelson, MD
- Urinary Tract Infections 90
- Meningitis 38
- Renal Abscess (Intrarenal and Perinephric) 93
- Encephalitis 41
- Pelvic Inflammatory Disease and Cervicitis 94
- Subdural Empyema and Epidural Abscess 43
- Infectious Diseases in the Sexually Abused Child 96
- Brain Abscess 45
- Ventricular Shunt Infections 46
Chapter 13: Skin and Soft Tissue Infections 98
Laura Gomez, MD and Stephen C. Eppes, MD
Chapter 8: Upper Respiratory Tract Infections 48
- Impetigo 98
Susmita Pati, MD MPH, Nicholas Tsarouhas, MD,
- Cellulitis 100
and SamirS. Shah, MD
- Folliculitis, Furuncles, and Carbuncles 101
- Pharyngitis 48
- Necrotizing Fasciitis 102
- Peritonsillar/Retropharyngeal Abscess 49
- Croup 52
Chapter 14: Bone and Joint Infections 105
- Otitis Media 53
Jane M. Gould, MD,FAAP
- Mastoiditis 56
- Septic Arthritis 105
- Sinusitis 57
- Osteomyelitits 107
- Cervical Lymphadenitis 59
Chapter 15: Bloodstream Infections Ill
Chapter 9: Lower Respiratory Tract Infections 62
Arlene Dent, MD, PhD and John R. Schreiber, MD, MPH
SamirS. Shah, MD
- Sepsis Ill
- Bronchiolitis 62
- Central Venous Catheter-Related Infections 114
- Acute Pneumonia 64
-Toxic Shock Syndrome 116
--------------------------------------- 135
x
Blueprints Urology
Contents
xi
Chapter 16:Trauma-Related Infections 119
Chapter 22: Inherited Immune Deficiencies 170
Reza J. Daugherty, MD, and Dennis R. Durbin, MD, MSCE
Timothy Andrews, MD and Elena Elizabeth Perez, MD, PhD
- Infections Following Trauma 119
- Evaluation of Suspected Primary immunodeficiency 170
- Infections Following Bites 121
- Humoral (Antibody) Deficiency 173
- Infections Following Burns 122
--------------------------------------- 136
Contributors
Matthew J. Bizzarro, MD
Contributors
Fellow-Neonatology
Yale-New Haven Hospital
New Haven, Connecticut
Kurt A. Brown, MD
Associate Director Clinical Research
Elizabeth R. Alpern, MD, MSCE
AstraZeneca LP
Assistant Professor of Pediatrics
Wilmington, Delaware
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
Susan Coffin, MD,MPH
Attending Physician
Assistant Professor, Department of Pediatrics
Division of Emergency Medicine
University of Pennsylvania School of Medicine
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
Philadelphia, Pennsylvania
Attending Physician
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
Timothy Andrews, MD
xiii
--------------------------------------- 137
xiv
Contributors
Contributors
xv
Attending Physician
Associate Director, Infectious Diseases
Alfred I. DuPont Hospital for Children
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
Wilmington, Delaware
Leila M. Khazaeni, MD
Patrick G. Gallagher, MD
Associate Professor
Assistant Instructor, Department of Ophthalmology
Department of Pediatrics
University of Pennsylvania School of Medicine
Yale University School of Medicine
Philadelphia, Pennsylvania
New Haven, Connecticut
Resident
Attending Physician
Scheie Eye Institute
Philadelphia, Pennsylvania
Yale-New Haven Hospital
New Haven, Connecticut
Jean O. Kim,MD
Andrew L. Garrett, MD, FAAP, EMT
Pediatric Infectious Disease Specialist
Instructor in Pediatrics and Emergency Medicine
Germbusters, P.C.
University of Massachusetts Medical School
Hoffman Estates, Illinois
Worcester, Massachusetts
Fellow in EMS and Disaster Medicine
Petar Mamula, MD
Attending Physician in Pediatric Emergency Medicine
Assistant Professor of Pediatrics
University of Massachusetts Memorial Health Care
University of Pennsylvania School of Medicine
Worcester, Massachusetts
Philadelphia, Pennsylvania
Attending Physician, Division of Gastroenterology and Nutrition
Laura Gomez, MD
The Children's Hospital of Philadelphia
Department of Pediatrics
Philadelphia, Pennsylvania
Thomas Jefferson University
Philadelphia, Pennsylvania
Marian G. Michaels, MD, MPH
Alfred I. DuPont Hospital for Children
Associate Professor of Pediatrics and Surgery
Wilmington, Delaware
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania
Jane M. Gould, MD, FAAP
Allergy, Immunology and Infectious Diseases
Attending Physician
Children's Hospital of Pittsburgh
The Children's Hospital of Philadelphia
Pittsburgh, Pennsylvania
Philadelphia, Pennsylvania
Monte D. Mills, MD
Richard L. Hodinka, PhD
Director of Ophthalmology
Associate Professor, Pediatrics
The Children's Hospital of Philadelphia
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
Philadelphia, Pennsylvania
Director, Clinical Virology
Karin L. McGowan, PhD, F(AAM)
The Children's Hospital of Philadelphia
Associate Professor
Philadelphia, Pennsylvania
Department of Pediatrics
University of Pennsylvania School of Medicine
Ron Keren, MD, MPH
Philadelphia, Pennsylvania
Assistant Professor of Pediatrics
Director, Microbiology
University of Pennsylvania School of Medicine
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
Philadelphia, Pennsylvania
--------------------------------------- 138
'leaicai review
Blueprints for your pocket!
This book has great format and content for a
and may also be used as a reference on a normal pediatric
rotation since much of peds deals with infections.
1st year resident. Family Practice, University of North Dakota
For your elective rotations or studying for USMLE Steps 2 and
3, get a copy of Blueprints Pediatric Infectious Diseases. This
new pocket-sized Blueprint is just what you need for a quick
understanding of the essentials for a test, or to impress your
attending. Also a valuable resource if you didn't have a pediatric
infectious disease rotation, but would like to learn more.
Feature
High yield for commonly encountered conditions
Commonly prescribed medications
Self-test Q&A section
Career and residency opportunities appendix
The material is very clearly written and the format is helpful,
as it is quick and easy to follow. The Q&A section is probably
one of the most important sections in such a book.
4th year medical student,
Drexel University College of Medicine
The chapters put together in one "package" information about
the disease that would have to be sought in various textbooks
and other educational resources ...All the important aspects
of pediatric infectious diseases presented in each chapter... I
would recommend this book to any student.
4th year medical student,
Howard University College of Medicine
student.com
90000
Blackwell
Publishing
9"781405"104029"